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ABSTRACT 
Goniothalamus tapisoides Mat Salleh, a plant from Annonaceae family, has been 
studied. Collected from Sarawak, the bark of this plant were dried and grounded before 
phytochemical study was performed. The chromatographic separation on the 
dichloromethane extracts of the bark gave eleven compounds – six known and five new. 
Six known compounds were identified as goniothalamin 1, pterodondiol 164, 
liriodenine 114, 9-deoxygoniopypyrone 15, benzamide 161 and cinnamic acid 155. Five 
new compounds are goniomicin A 157, goniomicin B 158, goniomicin C 159, 
goniomicin D 160 and tapisoidin 162. 
 
 
 
 
 
 
 
 
 
 
 
 
  
ABSTRAK 
Goniothalamus tapisoides Mat Salleh, sejenis tumbuhan dari famili Annonaceae, telah 
dikaji. Dikumpulkan dari Sarawak, bahagian kulit pokok tumbuhan ini terlebih dahulu 
dikering dan dikisarkan sebelum kajian fitokimia dijalankan. Pemisahan secara  
kromatografi pada ekstrak diklorometana untuk bahagian kulit telah memencilkan 
sebelas sebatian – enam dikenali dan lima baru. Enam sebatian yang dikenali telah 
dipencilkan daripada bahagian kulit telah dikenalpasti sebagai goniotalamin 1, 
pterodondiol 164, liriodenina 114, 9-deoxygoniopypyron 15, benzamida 161 and asid 
sinamik 155. Lima sebatian yang baru adalah goniomicin A 157, goniomicin B 158, 
goniomicin C 159, goniomicin D 160 dan tapisoidin 162. 
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1.1 Introduction 
The term natural products today quite commonly refer to herbs, herbal 
concoctions, dietary supplements, traditional Chinese medicine, or alternative 
medicine.
1
 In fact, natural products are usually either of prebiotic origin or originate 
from microbes, plants or animals sources which are secondary metabolites with 
molecular weight less than 2000 amu produced by a living organism that are not strictly 
necessary for the survival of the organism.
 Secondary metabolites are produce in response to
 
needs and 
challenges of the 
natural environment.
2
  
Nature has been a source of therapeutic agents since early human history and an 
impressive number of modern drugs have been derived from natural sources, which 
many of it based on their use in traditional medicine. Over the last century, a number of 
top selling drugs have been developed from natural products for example vincristine 
from Vinca rosea, morphine from Papaver somniferum and Taxol from Taxus brevifolia. 
In recent years, a significant revival of interest in natural products as a potential 
source for new medicines has been observed among academia as well as pharmaceutical 
companies.
2
 According to Cragg et al, 39% of 520 new approved drugs between 1983 
and 1994 were natural products or their derivatives, and 60-80% of antibacterial and 
anticancer drugs were from natural origins. In 2000, approximately 60% of all drugs in 
clinical trials for the multiplicity of cancers had natural origins.
2
 
Secondary metabolites keep evolving as nature are continually carrying out its 
own version of combinational chemistry for the over 3 billion years during which 
bacteria have inhabited the earth. For the useful metabolites, the biosynthetic genes 
were retained, and genetic modifications further improved the process. Combinatorial 
chemistry occurred by nature is much more sophisticated than in the laboratory.  
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Therefore, a great amount and different variety of natural products have been 
found naturally. The total numbers of natural products have been estimated to be over 
500,000 in the world. Until today, there are about 160,000 natural products have been 
identified and this value is estimated increasing by 10,000 per year.
 3
 
The earliest medicinal plant research in Malaysia was on phytochemical survey 
of plants in Malaysia that was carried out by Arthur in 1954 and later the screening of 
200 species for Peninsular Malaysia for the presence of alkaloids were carried out. 
4
 
These two publications marked the beginning of medicinal plant research in Malaysia.  
Malaysia has about 12,000 species of flowering plants of which about 1,300 are 
said to be medicinal and only about a hundred have been investigated fully for their 
potential.
5
 Due to the medicinal importance of natural products, the author has 
embarked the study of the chemical constituents from the stem bark of Goniothalamus 
tapisoides that belongs to the family of Annonaceae. This genus is known to produce 
compounds with cytotoxic activity such as goniothalamin.
17
 In this study, chemical 
constituents will be isolated and structurally elucidated using various chromatographic 
and spectroscopic techniques. To the knowledge of the author the chemical constituents 
of this plant has never been reported. 
 The objectives of the project are threefold. First, to isolate chemical constituents 
from species Goniothalamus tapisoides by using chromatographic methods. The 
chromatographic methods we used are column chromatography, thin layer 
chromatography (TLC) and flash column. Second, structural elucidation on the 
components which is carried out by NMR and mass spectroscopy (MS). And finally, 
cytotoxic studies on several cell lines (lung, prostate, skin, pancreatic, liver, colon and 
breast) will be carried out on the isolated compounds. 
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1.2 Annonaceae: Distribution and Habitat5,6,7,8 
The Annonaceae (custard-apple family) is the most diverse family of primitive 
angiosperms with about 200 genera and 2500 species. It is suggested that the early 
diversity centre of Annonaceae is in the north part of West Gondwanaland. Thus, the 
family Annonaceae has come into existence since late Cretaceous.  
Annonaceae is a pantropical family that well developed in tropical regions 
mainly at low elevations in moist forests. Except for two related North American genera 
(Asimina and Deeringothamnus), generally they are distributed over the tropical areas of 
America, Africa and Asia.  
According to Takhtajan, 30 genera and 740 species are found in America 
continent. While 40 genera and 450 species are found in Africa and Madagascar. These 
show that the genus have better diversity in America continent compared to Africa and 
Madagascar. While in Asia alone, about 60 genera and 1000 species can be found. 
Within Asia area, Indo-Malaysia has greatest concentration of genera and species 
compared to others area. 
Annonaceae is a family of woody, resinous plants, comprising only trees, shrubs 
and climbers, whose fruits are, bunches of big-seeded berries for the detection of such 
animals as squirrels, monkeys and bats. Annonaceae is commonly known by Malays as 
‘Pisang-Pisang’ or variants of this on account of the bunch of carpels suggesting 
bananas. 
 The plants of this order are very important economically, pharmacologically and 
nutritionally. The seeds of the Annonaceae plants can produce edible oil and soap. The 
wood can be used to manufacture alcohol and the fragrant flowers like Cananga 
odorata, are important as raw material for the perfumery industry. 
Introduction  Chapter 1 
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1.3 Annonaceae : General Appearance and Morphology9,10,11,12 
The trees of Annonaceae are shrubs, erect or climbing. They may reach more 
than 4 meters high and the shrub may go to about 30 cm high. The bark usually smooth 
and entire, pale grey or buff to brown. The twigs are pubescent or tomentose, but rarely 
glabrous. Young twigs become glabrous sooner or later. 
The leaves are always simples, alternate and entire without stipules and 
membranous or coriceous. The base may be acute, rounded, emiginate, ordate or 
unequal sided. The apex is acute, acuminate or less often obtuse. 
The flowers are usually solitary and accented. The scented flowers are very 
famous and the most popular species with fragrant flowers is Cananga ordorata 
(Ylang-ylang) when the flower is not solitary, the influorescense is often a few flower 
cyme, usually condensed. The petals have a wonderful diversity and are of the greatest 
diagnostic value in Annonaceae. 
The stamens are normally numerous, arranged in spirals on a convex or slightly 
flattened torus. The apex may be oblique, truncate, flat topped, two lobed with a little 
depression in the middle, convex, conical or produced into long point. 
The ovaries are usually oblong, cylindric, terete or angled and occasionally 
slightly falcate. They are usually covered with a pubescent or tomentose indumentums. 
The style may be present or absent. When present it is short as in Monocarpia and 
Popowia or elongated and slender as in Xylopia and Goniothalamus. In all genera the 
stigma is split or slightly grooved on the top. 
The fruits of Annonaceae are very important role in determining the genera. In 
fact, Annonaceae are subdivided into two subfamilies, Annonaideae and 
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Monodoroideae on the basis of the fruit alone. In Annonaideae a great majority has 
apocarpous carpels. They are stalked or sessile whereas in a few generathe carpels are 
united into a many called syncarp with erect stigmas. While in Monodoroideae, the 
carpels are united into a one celled ovary with placentation and radiating stigmas. 
Classification and determination of a genus is dependent on a combination of 
characters, for instance that of the petal and the fruit. There are 38 genera, 198 native 
and 5 cultivated species besides 17 varieties of Annonaceae in Penisular Malaysia. 
Scheme 1 and Table 1 illustrate the summarized classification made by Sinclair. 
 
Scheme 1.1: Classification of Annonaceae 
 
Family Annonaceae 
 
 
Sub-Family 
Annonaideae 
Sub-Family 
Monodoroideae 
 
 
 
Tribes Tribes 
 
 
 
 Uvaria 
 Miliuseae 
 Unoneae 
 Xylopieae 
 Mitiphoreae 
 Monodora 
 Isolana 
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Table 1.1: Genera of Annonaceae 
Tribes Genera 
Uvarieaea Sageraea 
Stelechocarpus 
Kingstonia 
Enicosanthum 
Trivalvaria 
Uvaria 
Cyathostemma 
Rauwenhoffia 
Ellipeia 
Unoneae Cyathocalyx 
Artobotrys 
Desmos 
Monocarpia 
Oncodostigma 
Polyalthia 
Cananga 
Mezzettia 
Disepalum 
Meiogyne 
Xylopeae Xylopia 
Anaxagorea 
Fissistigma 
Pyramidanthe 
Mitrella 
Melodorum 
Miliuseae Marsipopetalum 
Phaeanthus 
Miliusa 
Alphonsea 
Platymitro 
Orophea 
Mitiphoreae Pseuduvaria 
Neo-Uvaria 
Goniothalamus 
Oxymitra 
Mitrephora 
Popowia 
Annonineae Annona 
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1.4 Genus - Goniothalamus13 
Goniothalamus is one of the largest genera of paleotropical Annonaceae with 
over 120 species distributed throughout the tropics and subtropics with some species 
being used widely as traditional medicines. The trees of genus Goniothalamus are 
normally shrubs and small trees. The leaves are leathery or papery. The nerves are 
prominent with ladder-like reticulations or indistinct with lax network of reticulations. 
While for the flowers, they are usually axillary, sometimes terminal or cauliflorous. 
 For more specific, the petals reveal in the form of valvate, quite leathery and 
outer larger than inner. This genus also has many stamens with quite linear-oblong, 
connectives apiculate and flat topped or convex. The ovaries are numerous, cylindrical, 
pubescent or glabrous with the style of linear and grooved on the anterior side. The 
stigmas are more or less funnel shaped with two lobed, rarely cylindrical and truncate. 
The fruits are stalked or sessile with 1-2 seeds. 
 In regards to the pharmacological potentials of Goniothalamus species, there is 
evidence to suggest that this taxon has the ability to elaborate series of acetogenins and 
styryl lactones which are cytotoxic against a broad array of cancer cells including breast, 
colon, kidney and pancreatic carcinoma cells. 
1.5 Botanical Aspect of Goniothalamus tapisoides Mat Salleh14 
G. tapisoides Mat Salleh is known as ‘selada’ by the Malays or ‘semukau’ by 
the Iban. It is a small tree around 5 m in height. It is endemic to Borneo, especially the 
sourthern part of Sarawak. 
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1.6 Traditional Medicinal Uses of Goniothalamus species 
Plant from Goniothalamus species have been used as folk medicine in several 
countries such as Malaysia, Indonesia, Taiwan and Philppines.
13
 Table 1.2 lists the 
medicinal uses of some Goniothalamus species on the basis of reference 13. 
Table 1.2: The medicinal uses of Goniothalamus species 
Goniothalamus species & 
Localities 
Part of 
Plant 
Treatments 
1. G. amuyon 
 
Peninsular Malaysia, 
Taiwan and 
Philippines 
Seeds 
 
 
 
 
 
 
 
Fruits 
 
 
 In Taiwan, the seeds are used to treat 
scabies. 
 In Philippines, the seeds are evoked with 
oil make an effective liniment to treat 
rheumatism. 
 And also decoctions of seeds are used to 
treat tymparites. 
 
 In Philippines, the fruits are used to treat 
stomachic. 
2. G. dolichocharpus 
 
Peninsular Malaysia 
Roots  The roots are boiled and taken orally by 
the Kelabit community to ease 
stomachache. 
 
3. G. giganteus 
 
Peninsular Malaysia 
Roots 
 
 
Leaves 
 
 The roots are used to abort and treat colds. 
 
 The heated leaves are applied to 
swellings. 
 
4. G. macrophyllus 
 
Peninsular Malaysia 
and Jawa, Indonesia 
Leaves 
 
 
 
 
 
Roots 
 The leaves are used to abrogate fever. 
 
 The burnt leaves also been noted to be 
fragrant and are an effective mosquito 
repellent. 
 
 The decoction of roots is given as a 
postpartum remedy and to cause abortion. 
 
 
 
Introduction  Chapter 1 
9 
 
Goniothalamus species & 
Localities 
Part of 
Plant 
Treatments 
5. G. scortechinii 
 
Peninsular Malaysia 
  A decoction of this species alone or in 
mixture is given as a postpartum 
protective medicine. 
 
 In Malay, it is used to improve blood 
circulation. 
 
6. G. tapis 
 
Peninsular Malaysia, 
Borneo and Indonesia 
Roots 
 
 
 
 
Bark 
 
 The roots are used an abortifacient during 
early months of pregnancy. 
 In Java, Indonesia, an infusion of the roots 
is used to treat typhoid fever. 
 
 In Indonesia, the bark is used as mosquito 
repellent. 
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2.1 General15 
The chemical compositions of a plant cannot be defined precisely for a given 
tree or even tree of same species. Chemical composition varies with tree part, type of 
plant geographic location, climate and soil conditions. However generally, plant of the 
same species shows same chemotaxonomic similarities.  
Chemicals from plants can be broadly classified as primary and secondary 
compounds or metabolites. The primary metabolites are in all cells and play a central 
role in metabolism and reproduction of those cells. These compounds include the 
nucleic acids, common amino acids and sugars. Most primary metabolites exert their 
biological effect within the cell or organism that is responsible for their production. 
Secondary metabolites have a restricted distribution and are often characteristic of 
individual genera, species or strains and they are formed along specialized pathways 
from primary metabolites. They are non-essential to life. 
For a long time there was no clear role of secondary metabolites and they were 
often described as waste products of the plant’s metabolism. Today we consider them as 
the means by which the plant interacts with other organisms in the immediate 
environment. Therefore secondary metabolites have been attracted interest because of 
their biological effect on other organisms.  
Drugs, coloring matters, essential oils, flavoring substances are example of 
natural products obtained from the forest. Secondary metabolites are the minor 
component of plants. They are termed as extractives since they do not form part of the 
cell wall structure and can often be extracted by means of suitable organic solvents and 
water without destroying the structure of the plant tissues. 
General Chemical Aspects  Chapter 2  
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The chemical examination of secondary compounds has been a major aspect in 
the development of organic chemistry. Their chemical structures are complex and 
diverse and cover almost the whole spectrum of organic chemicals. Alkaloids, 
terpenoids, styryl-lactones, acetogenins, tannins, resins, flavonoids and glycosides are 
the examples of secondary compounds. Many of these compounds have marked 
physiological properties and some have been or are important substances in industries 
and medicine. The biologically active constituents of medicinal, commercial and 
poisonous plants have been studied and it have been estimated that over 40% of 
medicines have their origins in these natural products.  
Styryl-lactones and acetogenins are two major types of bioactive compounds 
isolated from Goniothalamus species. Other types of compounds also found in 
Goniothalamus species are alkaloids, terpenes and flavonoids. Interestingly, both styryl-
lactones and acetogenins are completely different in terms of chemical structures but 
their cellular activities are involving the mitochondria in mammals. In this study, author 
had been aiming for styryl-lactones compounds and discussed briefly the general 
chemical aspects of other interesting chemical constituents of Goniothalamus plants. 
2.2 Styryl-lactones15,16 
 Styryl-lactones are a group of secondary metabolites isolated mainly from 
various species of shrubs and trees. The styryl-lactones are found primarily in the 
Goniothalamus species (Annonaceae) that have demonstrated to posses interesting 
biological properties. Styryl-lactones have been reported to posses cytotoxic, anti-tumor, 
pesticidal, teratogenic and embryotoxic activities. 
 Styryl-lactones are low molecular weight phenolic compounds which have basic 
skeleton of 13 carbon atoms that includes (as the name styryl-lactone implies) a styryl 
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or pseudo-styryl fragment linked to a lactone moiety. Styryl-lactones are cytotoxic 
secondary metabolites having γ-, δ-, or ζ-lactone rings. Over 30 different styryl-lactones 
have been isolated and described from various species of Goniothalamus. 
 Styryl-lactones can be classified into six groups based on the structural 
characteristics of the skeletons. These groups are; styryl-pyrones, furano-pyrones, 
furano-furones, pyrano-pyrones, butenolides , and heptolides. 
2.2.1 Styryl-pyrones17 
Goniothalamin 1, goniodiol 2 and etharvendiol 3 are some members of this group. 
O O
 
1 
O O
OH
OH
 
2 
O O
OH
OH
EtO
 
3 
Goniothalamin 1 was firstly isolated from the dried bark of Cryptocarya 
caloneura in the year 1967. Later it was isolated from Cryptocarya moschata, and 
various species of Goniothalamus. Goniothalamin 1 is the first styryl-lactone found in 
Annonaceae, it shows a potent mosquito larvicide, weak bacterial and significant 
antifungal activity against a wide range of gram-positive and gram-negative bacteria 
and fungi. 
O
O
 
4 
General Chemical Aspects  Chapter 2  
 
13 
 
(R)-Goniothalamin 4 has displayed in vitro cytotoxic effect especially by 
inducing apoptosis on different cancer cell lines [cervical carcinoma (Hela); gastric 
carcinoma (HGC-27); breast carcinoma (MCF-7, T47D, MDA-MB-231); leukemia 
(HL-60), ovarian carcinoma (Caov-3)]. Interestingly, this effect was shown to be 
selective for cancer cell lines with no significant cytotoxicity toward non-malignant 
cells. 
2.2.2 Furano-pyrones 
The furano-pyrone skeleton represents the second most abundant class of styryl 
lactones in Goniothalamus. Altholactone 5, also called goniothalenol, is the first 
member in this group that was first identified from Polyalthia and eight years later was 
isolated from several species of Goniothalamus. Others example of this group are 
isoaltholactone 6, 2-epi-altholactone 7, goniofupyrone 8, goniotharvensin 9, and 
etharvensin 10. 
O O
O
HO
 
5 
O O
O
HO
 
6 
O
O
O
HO
 
7 
 
O
O
O
OH
H
HO
 
8 
 
O
O
O
HO
H
H
 
9 
 
O
O
O
HO
OEt
H
 
10 
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2.2.3 Furano-furones18 
Goniofufurone 11 and 7-epi-goniofufurone 12 are members of this group. They 
are isolated from the stem bark of G. giganteus. Goniofufurone 11 has cytotoxic activity 
against A-549 (human lung carcinoma), MCF-7 (human breast adenocarcinoma) and 
HT-29 (human colon adenocarcinoma) cell lines with ED50 < 4 g/ml. 
O
O
OH
HO
O 
11 
O
O
OH
HO
O  
12 
2.2.4 Pyrano-pyrones19 
The examples of pyrano-pyrone styryl lactones are goniopypyrone 13, 
leiocarpin-A 14 and 9-deoxygoniopypyrone 15. They are also exhibiting non-selective 
activity against human tumour cell lines. 
O
O
O
HO
H
H
HO
H
 
13 
 
O
HO
O
O
 
14 
O
O
O
HO
H
H
H
 
15 
2.2.5 Butenolides20 
Two well known compounds in this group are goniobutenolide-A 16 and 
goniobutenolide-B 17. They were isolated from G. giganteus. Biological activity of 
goniobutenolide-A 16 was tested against four different tumour cell lines (HL-60, HCT-
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8, MDA/MB-435 and SF295) and it has no effect on cell lines HL-60, MDA/MB-435 
and SF295, but for the cell line HCT-8 a modest cytotoxicity was observed (IC50 = 
101.5 M). 
O
O
OH
OH
 
16 
OH
OH
O
O
 
 
17 
2.2.6 Heptolides21 
In this group, gonioheptolides-A 18 and gonioheptolides-B 19 were isolated 
from the stem bark of G. giganteus. Almuheptolides-A 20 and Almuheptolides-B 21 
were isolated from the stem bark of G. arvensis. Compounds of this group contain a 
saturated eight-membered lactone moiety. 
O
HO
O
OH
OMe
OH
 
18 
O
HO
O
OH
OEt
OH
 
19 
O
EtO
O
OH
OEt
OH
 
20 
O
H
O
OH
OEt
OH
 
21 
2.3 Acetogenins22,23,24 
Acetogenins are naturally occurring polyketides which have so far only been 
characterized from members of the family Annonaceae including in the genus 
Goniothalamus particularly, G. giganteus, G. donnaiensis, and G. gardenri. Uvaricin 
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was first discovered by Jolad in 1982, and then scientists have been isolated more than 
400 acetogenins in the past 25 years from Annonaceae family. The general skeleton of 
acetogenins is unbranched C35-C37 fatty acid, terminated with a 2,4-disubstituted-γ-
lactone (sometimes rearranged to a 2,4-disubstituted ketolactone) moiety. Several 
oxygenated functions, such as hydroxyl, ketone, epoxide, tetrahydrofuran (THF) and 
tetrahydropyran (THP) may be present, as well as double and triple bonds. Thus several 
types of acetogenins have been characterized based on the nature of functional groups 
which are present. 
Structurally, most of these acetogenins may be classified into six major groups, 
i.e. non-tetrahydrofuran (THF), mono-THF, adjacent bis-THF, non-adjacent bis-THF, 
tri-THF and tetrahydropyran (THP) acetogenins. They can be sub grouped again 
according to the form of the γ-lactone ring (unsaturated γ-methyl-γ-lactone, a propanone 
substituted unsaturated γ-lactone or a β-hydroxy-γ-methyl-γ-lactone). 
All acetogenins contains multiple stereocenters, the elucidation of which often 
presents stereochemical problems. Acetogenins do not form crystals suitable for X-ray 
crystallographic analysis due to their waxy nature. Acetogenins are very potent 
inhibitors of the NADH-ubiquinone reductase (Complex I) activity of mammalian 
mitochondria. As very potent mitochondrial inhibitors, the acetogenins are a class of 
promising anticancer, anti-infective, and pesticidal natural compounds.  
2.3.1 Non-tetrahydrofuran25 
Acetogenins within this group is linear. The examples of non-THF are 
donhepocin 22, 34-epi-donhepocin 22’, donhexocin 23 and donbutocin 24. They were 
isolated from G. donnaiensis; 22 and 22’ containing rare γ-hydroxymethyl-γ-lactone 
that isolated as an epimeric pair. 
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O
O
OH
OH
OH
OH
OH OH
OH
 
22(22’) 
O
O
OH
OH
OH
OH
OH OH
 
23 
O
O
OH
OH
OH OH
 
24 
2.3.2 Mono-tetrahydrofuran26 
Gigantransenins A 25, B 26 and C 27 are three examples of mono-THF 
acetogenins that isolated from the bark of G. giganteus. Gigantransenins A, B and C are 
the first examples of acetogenins having trans double bonds. They also showed 
selective inhibitory effects on the human breast tumor cell-line (MCF-7) comparable 
with the potency of adriamycin.  
OH
O
OH
OH
OH
O
O
 
25 
OH
O
OH
OH
OH
O
O
  
26 
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O
OH
OH
OH
O
O
OH
 
27 
2.3.3 Adjacent bis-tetrahydrofuran 
Goniodenin 28, asimilobin 29 and longimicin C 30 are examples of adjacent bis-THF 
that isolated from G. giganteus. 
O O
O
OH
OH O
 
28 
O O
O
OH
OH O
 
29 
O O
O
OH
OH OOH
 
30 
2.3.4 Non-adjacent bis-tetrahydrofuran 
Goniotriocin 31, gigantecin 32 and 4-deoxygigantecin 33 are some members of this 
group. They are also isolated from G. giganteus. 
O
O
O
OH
OH
O
OH O
 
31 
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OH
O
OH
OH
O
OH
O
O
 
32 
OH
O
OH
OH
O
O
O
 
33 
 
2.3.5 Tri-tetrahydrofuran 
Goniocin 34 is the first compounds having tri-tetrahydrofuran (THF) moiety that had 
been isolated from G. giganteus. Until now there are the only tri-THF had been isolated 
from this genus. 
OH
O O O
OH
O
O
 
34 
 
2.3.6 Tetrahydropyran27 
Pyranicin 35 and pyragonicin 36 are the first mono-THP acetogenins. Both 
pyranicin and pyragonicin exhibited a selective cytotoxic against the pancreatic cell line 
(PACA-2) in a panel of six human solid tumor cell lines, with pyranicin showing ten 
times the potency of adriamycin. 
O
OH
OH OH
O
O
HO
 
35 
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36 
2.4 Terpenes28 
 Terpenes are natural lipid products that are built up from isoprene units. An 
isoprene unit is a five-carbon unit with the connectivity of the molecule isoprene. 
Terpenes are classified by the number of isoprene units that they contain (Table 2.1). 
Terpenes are responsible for many of the flavour, fragrances, and colours of plants. 
Some are plant hormones, pheromones, poisons, or drugs.  
Table 2.1: Common Classification of Terpene Groups 
Group No. of carbon Isoprene unit 
Monoterpene 10 2 
Sesquiterpene 15 3 
Diterpene 20 4 
Sesterterpene 25 5 
Triterpene 30 6 
Tetraterpene 40 8 
 
 Friedelin 37, friedelinol 38 and betullinic acid 39 are examples of triterpene that 
isolated from G. thwaitessi.  
O
H H H
 
37 
HO
H H H
 
38 
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O
H
H COOH
H
H
 
39 
 
 
 
2.5 Alkaloids 
Several classes of compounds such as azaanthraquinones, aristolactams, 
aporphines and amino-napthoquinones types of alkaloids have been reported in this 
genus. For example there are five alkaloids isolated from the stems of G. amuyon; 
liriodenine 40, griffithazanone A 41, griffithazanone B 42, velutinam 43 and 
cepharanone B (aristolactam BII) 44. 
 
N
O
O
O
 
40 
 
O
OOH
N
H
R
O
 
   41 R=OH 
42 R=H 
NH
O
MeO
OMe
R
 
   43 R=OH 
44 R=H 
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2.6 Flavonoids 
Flavonoids are polyphenolic compounds possessing 15 carbon skeleton arranged 
in C6-C3-C6 fashion. In biological roles, flavonoids are important plant pigments for 
flower colouration producing yellow or red/blue pigmentation in petals designed to 
attract pollinator animals. 
Several flavonoid compounds have been found in Goniothalamus species.  
Among them is pinocembrine 45, it has been isolated from G. borneensis, G. giganteus, 
G. laoticus and G. macrophyllus. 
OHO
OH O  
45 
Many Goniothalamus species have been studied before. Table 2.2 lists all types of 
compounds isolated from Goniothalamus species. 
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Table 2.2: Chemical Constituents from Goniothalamus species 
Species and Compounds Type Reference 
G. amuyon 
7-Acetylgoniodiol 54 
8-Acetylgoniodiol 55 
8-Chlorogoniodiol 58 
9-Deoxygoniopypyrone 15 
7,8-diepimer-Goniotriol 62 
Goniotriol 60 
Goniothalamin 1 
Goniothalamin oxide 49 
8-Methoxygoniodiol 57 
Annonacin 73 
Corossolin 76 
Gigantriocin 84 
Cepharanone B 44 
Griffithazanone A 41 
Griffithazanone B 42 
Liriodenine 40 
Velutinam 43 
 
G. andersonii 
Iso-5-deoxygoniopypyrone 68 
Goniodiol 2 
Goniothalamin 1 
Goniothalamin oxide 49 
 
G. arvensis 
3-Acetylaltholactone 64 
5-Acetoxyisogoniothalamin oxide 50 
Almuheptolide A 20 
Almuheptolide B 21 
Altholactone 5 
2-epi-Altholactone 7 
Arvensin 65 
Etharvendiol 3 
Etharvensin 10 
Garvensintriol 63 
Goniofufurone 11 
Goniotharvensin 9 
Isoaltholactone 6 
 
G. borneensis 
Goniobutenolide A 16 
Goniobutenolide B 17 
Goniofufurone 11 
Goniothalamin 1 
Goniothalenol 5 
 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Pyrano-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Mono-THF 
Mono-THF 
Mono-THF 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
 
 
Pyrano-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
 
 
Furano-pyrone 
Styryl-pyrone 
Heptolide 
Heptolide 
Furano-pyrone 
Furano-pyrone 
Furano-pyrone 
Styryl-pyrone 
Furano-pyrone 
Styryl-pyrone 
Furano-pyrone 
Furano-pyrone 
Furano-pyrone 
 
 
Butenolide 
Butenolide 
Furano-furone 
Styryl-pyrone 
Furano-pyrone 
 
29
 
30
 
31
 
32
 
30 
30 
31 
31 
31 
33
 
33 
33 
34
 
34 
34 
30 
34 
 
 
35
  
35 
35 
35 
 
 
36
 
36 
21  
21 
37
 
38
 
38 
39
 
40
  
21 
21 
37 
37 
 
 
41
 
41 
41 
41 
41 
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Species and Compounds Type Reference 
 
Goniotriol 60 
Aristolactam A-III 134 
Goniothalactam 136 
Pinocembrine 45 
 
G. cardiopetalus 
Altholactone 5 
Cardiopetalolactone 66 
Goniopypyrone 13 
Cardiobutanolide 70 
Goniothalamin 1 
Goniodiol 2 
Goniofufurone 11 
Goniofupyrone 8 
 
G. cheliensis 
Cheliensisin A 51 
Goniothalamin 1 
Cheliensisin B 74 
Cheliensisin C 75 
Goniodiol 2 
Isoaltholactone 6 
Leiocarpin A 14 
Pinocembrine 45 
(3S)-2-oxo-5,12-dimethoxy-
methylbenz[f]indoline 125 
 
G. dolichocarpus 
9-Deoxyisogoniopypyrone 68 
Goniodiol 2 
Goniothalamin oxide 49 
Goniothalamin 1 
5-β-Hydroxygoniothalamin 47 
Annonacin 73 
 
G. donnaiensis 
Annonacin 73 
Donbutocin 24 
Donhepocin 22 
  34-epi-Donhepocin 22’ 
Donhexocin 23 
Donnaienin 77 
Donnaienin A 78 
  34-epi-Donnaienin A 
Donnaienin B 79 
  34-epi-Donnaienin B 
Donnaienin C 93 
  34-epi-Donnaienin C 
 
Styryl-pyrone 
Alkaloid 
Alkaloid 
Flavanoid 
 
 
Furano-pyrone 
Furano-pyrone 
Pyrano-pyrone 
Butenolide 
Styryl-pyrone  
Styryl-pyrone 
Furano-furone 
Furano-pyrone 
 
 
Styryl-pyrone  
Styryl-pyrone 
Mono-THF 
Mono-THF 
Styryl-pyrone 
Furano-pyrone 
Pyrano-pyrone 
Flavonoid 
Alkaloid 
 
 
 
Pyrano-pyrone 
Styryl-pyrone  
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Mono-THF 
 
 
Mono-THF 
Linear 
Linear 
Linear 
Linear 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
 
41 
42
 
41 
43
 
 
 
44
 
44 
44 
45
  
45 
45 
45 
45 
 
 
46
 
47
  
47 
47 
48
 
48 
48 
48 
49
 
 
 
 
50
 
50 
50 
50 
51
 
50 
 
 
52
 
53
 
53 
53 
54
 
55
 
52 
52 
52 
52 
56
 
56 
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Species and Compounds Type Reference 
 
Donnaienin D 118 
  34-epi-Donnaienin D 
2,4-cis-Gigantetrocinone 99 
  2,4-trans-Gigantetrocinone 
Goniodonin 85 
Goniothalamicin 77 
Isoannonacin 80 
Murisolin 79 
 
G. fulvus 
Goniothalamin 1 
 
G. gardneri 
Annonacin 73 
Isoannonacin 80 
Gardnerilin A 116 
Gardnerilin B 117 
Gardnerin 80 
Gardnerinin 81 
  34-epi-Gardnerinin 
Gigantetrocin A 82 
Gigantetrocin B 83 
Goniothalamicin 77 
Goniothalamusin 119 
2ʹ,4ʹ-dihydroxy-4,6- 
Dimethoxychalcone 141 
2ʹ,4ʹ-dihydroxy-4,6ʹ-
dimethoxydihydrochalcone 138 
2ʹ-hydroxy-4,4ʹ,6ʹ-
trimethoxydihydrochalcone 137 
4, 2ʹ,4ʹ-trihydroxy-6ʹ-
methoxydihydrochalcone 139 
(rel)-1β, 2α-di-(2,4-dihydroxy-6-
methoxybenzoyl)-3β, 4α-di-(4-
methoxyphenyl)-cyclobutane 142 
Annulatin 146 
Flavokawain A 140 
Mearnsitrin 145 
Naringenin trimethyl ether 143 
Tsugafolin 144 
 
G. giganteus 
8-Acetylgoniotriol 61 
Altholactone 5 
Goniobutenolide A 16 
Goniobutenolide B 17 
Goniodiol 2 
Goniofufurone 11 
 
Linear 
Linear 
Mono-THF 
Mono-THF  
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
 
 
Styryl-pyrone 
 
 
Mono-THF 
Mono-THF 
Linear 
Linear 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Linear 
Chalcone 
 
Chalcone 
 
Chalcone  
 
Chalcone 
 
Dihydrochalcone 
 
 
Flavonoid 
Chalcone 
Flavonoid 
Flavonoid 
Flavonoid 
 
 
Styryl-pyrone 
Furano-pyrone 
Butenolide 
Butenolide 
Styryl-pyrone 
Furano-furone 
 
56 
56 
53 
53 
53 
52 
52 
52 
 
 
57
 
 
 
58
 
58 
59
 
59 
58 
60
 
60 
58 
58 
58 
61
 
62
 
 
62 
 
62 
 
62 
 
62 
 
 
62 
62 
62 
62 
62 
 
 
63
 
64
 
65
 
65 
18 
63 
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Species and Compounds Type Reference 
 
7-epi-goniofufurone 12 
Goniofupyrone 8 
Gonioheptolide A 18 
Gonioheptolide B 19 
Goniopypyrone 13 
9-Deoxygoniopypyrone 15 
Goniothalamin 1 
Goniotriol 60 
Annomontacin 91 
4-Deoxyannomontacin 92 
cis-Annomontacinone 107 
  trans-Annomontacinone 
Annonacin 73 
2,4-cis-Isoannonacin 110 
  2,4-trans-Isoannonacin 
Asimilobin 29 
Giganenin 94 
Giganin 115 
Gigantecin 32 
4-Deoxygigantecin 33 
2,4-cis-Gigantecinone 114 
  2,4-trans-Gigantecinone 
Gigantetrocin 82 
4-Acetylgigantetrocin A 95 
2,4-cis-Gigantetrocinone 108 
  2,4-trans-Gigantetrocinone 
Gigantetronenin 96 
Gigantetronin 97 
Gigantransenin A 25 
Gigantransenin B 26 
Gigantransenin C 27 
Gigantriocin 84 
Gigantrionenin 101 
  cis-Gigantrionenin 102 
Goniocin 34 
Goniodenin 28 
Gonionenin 103 
2,4-cis-gonioneninone 109 
  2,4-trans-gonioneninone 
Goniotetracin 104  
Goniothalamicin 86  
Goniotriocin 31 
Goniotrionin 87 
Longicoricin 105 
Longifolicin 90 
Longimicin C 30 
Pyragonicin 36 
 
Furano-furone 
Furano-pyrone 
Heptolide 
Heptolide 
Pyrano-pyrone  
Pyrano-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Adjacent bis-THF 
Mono-THF 
Linear 
Non Adjacent bis-THF 
Non Adjacent bis-THF 
Non Adjacent bis-THF 
Non Adjacent bis-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
 Mono-THF 
Mono-THF 
Tri-THF 
Adjacent bis-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Non Adjacent bis-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Adjacent bis-THF 
Pyran 
 
18 
65 
66
 
66 
63 
18 
64 
67
 
68
 
69
 
69 
69 
70
 
71
 
71 
72
 
73
 
66 
74
 
73 
71 
71 
18 
75
 
69 
69 
68 
68 
26 
26 
26 
18 
68 
75 
76
 
72 
77
 
78
 
78 
78 
70 
79
 
78 
69 
69 
71 
27 
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Species and Compounds Type Reference 
 
Pyranicin 35 
Squamocin 120 
Xylomaticin 106 
2,4-cis-Xylomaticinone 111 
  2,4-trans-Xylomaticinone 
Pinocembrin 45 
 
G. grandiflorus 
Isoaltholactone 6 
 
G. griffithii 
8-Acetylgoniotriol 61 
8-Acetylgoniofufurone 67 
8-Acetylgoniopypyrone 69 
7-Acetylgoniodiol 54 
Altholactone 5 
9-Deoxygoniopypyrone 15 
Goniodiol 2 
Goniodiol diacetate 56 
Goniothalamin 1 
Goniotharvensin 9 
Goniofufurone 11 
Goniopypyrone 13 
Goniotriol 60 
Isoaltholactone 6 
Aristolactam A-II 134 
Griffithdione 121 
Griffithinam 135 
Griffithazanone A 41 
Griffithazanone B 42 
Taliscanine 133 
Velutinam 43 
 
G. howii 
Goniothalamin 1 
Howiinin A 52 
Howiicin A (Annonacin) 73 
Howiicin B 88 
Howiicin C 76 
Howiicin D 84 
Howiicin E 89 
Howiicin F 82 
Howiicin G 83 
 
G. laoticus 
2-epi-altholactone 7 
Altholactone 5 
3-Acetylaltholactone 64 
 
Pyran 
 Adjacent bis-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Flavonoid 
 
 
Furano-pyrone 
 
 
Styryl-pyrone 
Furano-furone 
Pyrano-pyrone 
Styryl-pyrone 
Furano-pyrone 
Pyrano-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Furano-pyrone 
Furano-furone 
Pyrano-pyrone 
Styryl-pyrone 
Furano-pyrone 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
 
 
Styryl-pyrone 
Styryl-pyrone 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
 
 
Furano-pyrone 
Furano-pyrone 
Furano-pyrone 
 
27 
76 
69 
79 
79 
64 
 
 
80
 
 
 
81
 
82
 
82 
82 
81 
81 
82 
82 
81 
81 
81 
82 
82 
82 
83
 
83 
83 
83 
83 
83 
83 
 
 
84
 
85
 
84 
84 
84 
86
 
86 
86 
86 
 
 
87
 
87 
88
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Species and Compounds Type Reference 
 
9-Deoxygoniopypyrone 15 
Goniotriol 60 
Goniofufurone 11 
Goniopypyrone 13 
Howiinin A 52 
Pinocembrine 45 
5-hydroxy-3-amino-2-aceto-1,4-
naphthoquinone 124 
Nordicentrine 123 
Cinnamic acid 155 
β-sitosterol 156 
 
G. leiocarpus 
7-epi-Goniodiol 53 
Goniothalamin 1 
Leiocarpin A 14 
Leiocarpin B 71 
Leiocarpin C 59 
Leiocarpin E 72 
Annonacin 73 
Corossolin 76 
Gigantriocin 84 
Murisolin 79 
 
G. macrophyllus 
Goniothalamin 1 
Goniothalamin oxide 49 
Pinocembrine 45 
 
G. malayanus 
Isoaltholactone 6 
 
G. marcanii 
Marcanine A 127 
Marcanine B 128 
Marcanine C 129 
Marcanine D 130 
Marcanine E 131 
Dielsiquinone 132 
5-hydroxy-3-amino-2-aceto-1,4-
naphthoquinone 124 
 
G. montanus 
Isoaltholactone 6 
 
G. ridleyi 
Goniothalamin 1 
Goniothalamin oxide 49 
 
Pyrano-pyrone 
Styryl-pyrone 
Furano-furone 
Pyrano-pyrone 
Styryl-pyrone 
Flavonoid 
Alkaloid 
 
Alkaloid 
 
 
 
 
Styryl-pyrone 
Styryl-pyrone 
Pyrano-pyrone 
 
Styryl-pyrone 
 
Mono-THF 
Mono-THF 
Mono-THF 
Mono-THF 
 
 
Styryl-pyrone 
Styryl-pyrone 
Flavonoid 
 
 
Furano-pyrone 
 
 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
Alkaloid 
 
 
 
Furano-pyrone 
 
 
Styryl-pyrone 
Styryl-pyrone 
 
88 
88 
87 
87 
88 
87 
87 
 
88 
88 
88 
 
 
89
 
90
 
89 
89 
89 
91
 
90 
90 
90 
90 
 
 
92
 
92 
93
 
 
 
94
 
 
 
95
 
95 
95 
95 
95 
95 
95 
 
 
 
94 
 
 
96
 
96 
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Species and Compounds Type Reference 
 
Isoaltholactone 6 
 
G. scortechinii 
Altholactone 5 
Goniofufurone 11 
Goniopypyrone 13 
Goniothalamin 1 
Goniotriol 60 
Crytomeridiol 154 
Pinocembrine 45 
Scorazanone 126 
 
G. sesquipedalis 
Goniodiol 2 
Goniodiol diacetate 56 
Goniothalamin 1 
5-Acetoxyisogoniothalamin oxide 50 
Goniotriol 60 
Gigantetrocin 82 
 
G. tamirensis 
9-Deoxygoniopypyrone 15 
8-epi-deoxygoniopypyrone 64 
 
G. tapis 
Arvensin 65 
Goniothalamin 1 
Isoaltholactone 6 
 
G. tenuifolius 
3,5,7,3’,4’-pentamethoxyflavone 148 
5,7,3’,4’-tetrahydroxy-3-methoxyflavone 149 
4’-hydroxy-3,5,7,3’-tetramethoxyflavone 152 
3’-hydroxy-3,5,7,4’-tetramethoxyflavone 153 
Aristolactam A-II 134 
Cepharanone B 44 
Kumatakenin 144 
Norcepharadione B 122 
Pachypodol 151 
Retusin 147 
Taliscanine 133 
Velutinam 43 
 
G. thwaitessi 
Annulatin 146 
Friedelin 37 
Friedelinol 38 
 
Furano-pyrone 
 
 
Furano-pyrone 
Furano-furone 
Pyrano-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Sesquiterpene 
Flavonoid 
Alkaloid 
 
 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
Mono-THF 
 
 
Pyrano-pyrone 
Pyrano-pyrone 
 
 
Furano-pyrone 
Styryl-pyrone 
Furano-pyrone 
 
 
Flavonoid 
Flavonoid 
Flavonoid 
Flavonoid 
Alkaloid 
Alkaloid 
Flavonoid 
Alkaloid 
Flavonoid 
Flavonoid 
Alkaloid 
Alkaloid 
 
 
Flavonoid 
Triterpene 
Triterpene 
 
96 
 
 
97
 
97 
97 
98
 
97 
99
 
97 
99 
 
 
43 
43 
100
 
101
 
43 
102
 
 
 
103
 
103 
 
 
104
 
98 
94 
 
 
105
 
105 
105 
105 
106
 
106 
105 
106 
105 
105 
106 
106 
 
 
62 
62 
62 
 
General Chemical Aspects  Chapter 2  
 
30 
 
Species and Compounds Type Reference 
 
Betullinic acid 39 
Mearnsitrin 145 
 
G. umbrosus 
5-Acetoxygoniothalamin 46 
Dehydrogoniothalamin 48 
Goniothalamin 1 
 
G. uvarioides 
5-Acetylgoniothalamin 37 
Goniothalamin 1 
 
G. velutinus 
Altholactone 5 
Goniothalamin 1 
Annonacin 73 
Aristolactam B-II 44 
 
Triterpene 
Flavonoid 
 
 
Styryl-pyrone 
Styryl-pyrone 
Styryl-pyrone 
 
 
Styryl-pyrone 
Styryl-pyrone 
 
 
Furano-pyrone 
Styryl-pyrone 
Mono-THF 
Alkaloid 
 
62 
62 
 
 
107
 
107 
107 
 
 
108
 
108 
 
 
109
 
109 
109 
109 
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Styryl-lactones 
O O
R  
R= OAc 46 
R= OH 47 
 
 
O O
 
48 
O
O
HO
R
 
R= H 49 
R= OAc 50 
R= OAc 51 
R= O-Cinnamoyl 52 
O
OR1
O
OR2
 
R1= Ac, R2= H 53 
R1= H, R2= Ac 54 
R1= Ac, R2= Ac 55 
R1= H, R2= Me 56 
R1= H, R2= Cl 57 
 
O
OH
OH
O
 
58 
OOH
OH
OH
O
 
59 
 
O
OH OR2
O
OR3
 
R1= H, R2= H 60 
R1= H, R2= Ac 61 
 
O
OH OH
O
OH
 
62 
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OO
OH
OH
OH
 
63 
O
O
O
OAc  
64 
 
O
O
O
OH
H
H
H
OH
H
 
65 
 
O
H
O
O
H
OH
H
H
 
66 
 
O
O
OAc
HO
O  
67 
 
O
O
O
HO
H
H  
68 
O
O
O
AcO
H
H
HO
H
 
69 
O
O
OH
OH
OH
OH
 
70 
 
O O
OH
H
OO
H
O OH
 
 
71 
 
O
O
H H
O
O
O
H
HHO
H
 
72 
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Acetogenins 
(CH2)n
O
OH R3
(CH2)n
O
R2
R1
O
 
Table 2.3: Mono THF Acetogenins with 35 carbons 
Compound Name Furan ring and 
Position 
R1 R2 R3 Others and 
Position 
73 Annonacin er/trans/er at 15 H OH OH OH at 10 
74 Cheliensisin B At 15 H OH OH OH at 10 & 11, 
strereochemitry 
not stated 
75 Cheliensisin C At 15 H OH OH OH at 10, 
strereochemitry 
not stated 
76 4-deoxyannonacin  
     =corossolin 
     =howiicin C 
th/trans/th at 15 H H OH OH at 10 
77 Donnaienin er/trans/er at 13 H OH OH OH at 10 & 15 
78 Donnaienin A 
     34-epi-donnaienin A 
er/trans/er at 15 OH OH OH mixture 
79 Donnaienin B 
     34-epi-donnaienin B 
trans/er at 9 H OH H OH at 17 & 18, 
(er),mixture 
80 Gardnerin  er/trans/er at 15 H OH OH OH at 8 & 10 
81 Gardnerinin 
     34-epi-gardnerinin 
trans/er at 11 OH OH H OH at 10, 19 & 
20 (er),mixture 
82 Gigantetrocin  
     =gigantetrocin A 
     =densicomacin-2 
     =howiicin F 
trans/th at 9 H OH H OH at 17 & 18 
(th) 
83 Gigantetrocin B 
     =howiicin G 
trans/th at 9 H OH H OH at 17 & 18 
(th), isomer of 
gigantetrocin 
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84 Gigantriocin 
     =howiicin D 
trans/th at 9 H H H OH at 17 & 18 
(th) 
85 Goniodonin er/trans/er at 13 OH OH OH OH at 10 
86 Goniothalamicin th/trans/th at 13 H OH OH - 
87 Goniotrionin th/trans/th at 9 H OH H OH at 16, cis 
db at 17-18 
88 Howiicin B 
     =murisolin 
th/trans/th at 15 H OH H - 
89 Howiicin E 
     =muricatetrocin A 
At 11 H OH H strereochemitry 
is not stated 
90 Longifolicin th/trans/th at 13 H OH OH - 
Note: er=erythro and th=threo; db=double bond 
 
(CH2)n
O
OH R3
(CH2)n
O
R2
R1
O
 
Table 2.4: Mono THF Acetogenins with 37 carbons 
Compound Name Furan ring and 
Position 
R1 R2 R3 Others and 
Position 
91 Annomontacin er/trans/er at 17 OH OH OH OH at 10 
92 4-deoxyannomontacin A er/trans/er at 17 H H OH OH at 10 
93 Donnaienin C 
     34-epi-donnaienin C 
er/trans/er at 15 OH OAc OH OH at 10, mixture 
94 Giganenin th/trans/th at 13 H H OH OH at 10 and db 
at 21-22 
95 4-acetylgigantetrocin A trans/th at 9 H OAc H OH at 17 & 18 
(th) 
96 Gigantetronenin trans/er at 9 H OH H OH at 17 & 18 
(th), cis db at 21-
22 
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97 Gigantetronin trans/th at 9 H OH H OH at 17 & 18 
(th) 
101 Gigantrionenin trans/th at 9 H H H OH at 17 & 18 
(th) 
102 cis-gigantrionenin cis/th at 9 H H H OH at 17 & 18 
(th) 
103 Gonionenin th/trans/th at 13 H OH OH cis, db at 21-22 
104 Goniotetracin th/trans/th at 13 H OH OH OH at 10 
105 Longicoricin er/trans/er at 15 H H OH OH at 10 
106 Xylomaticin th/trans/th at 15 H OH OH OH at 10 
Note: er=erythro and th=threo; db=double bond 
 
(CH2)n
O
OH R
(CH2)m
O
O
O
1
24
 
Table 2.5: Mono THF Acetogenins 
Compound Name No. of 
Carbons 
Position of 
Furan ring 
R Others and Position 
107 Annomontacin 37; m=11; 
n=12 
At 17 OH OH at 10; mixture of 2,4 cis 
and trans 
108 Gigantetrocinone 35; m=3; 
n=16 
At 9 H OH at 17 & 18 (th)    
mixture of 2,4 cis and trans  
109 Gonioneninone 37; m=7; 
n=14 
At 13 OH OH at 10; cis db at 21-22; 
mixture of 2,4 cis and trans 
110 Isoannonacin 35; m=9; 
n=10 
At 15 OH OH at 10; mixture of 2,4 cis 
and trans 
111 Xylomaticinone 37; m=9; 
n=12 
At 15 OH OH at 10; mixture of 2,4 cis 
and trans 
Note: er=erythro and th=threo; db=double bond 
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(CH2)4
(CH2)10
O
OH OH
O
HO
O
O
R
 
R=OH 112 
R=H 113 
(CH2)4
(CH2)10
O
OH OH
O
HO
O
O
O
24
9
 
114 (mixture of cis and trans) 
(CH3)11
R7
R8 R6
R5
R4 R3 R2
O
O
R1
19 15
8 4
 
 R1 R2 R3 R4 R5 R6 R7 R8 Others and Position 
115 H H H OH H H H H OH at 17&18 (er), 
cis db at 13-14 
116 H OH OH H OH OH OH OH 15&16 er, 19&20 er 
117 H OH H OH H H H H OH at 17&18 (th) 
118 OH OAc H OH OH OH OH OH 15&16 er, 19&20 er 
 Note: er=erythro and th=threo; db=double bond 
O
O
CH2OH  
119 
OH OH
O
O
OH
(CH2)12
O
O
H H
H H
 
120 
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Alkaloids 
NH
O
OMeO
MeO
R
 
R=Me 121 
R=H 122 
NH
O
O
H
OMe
MeO
 
123 
O
O
O
OH
NH2
 
124 
H
N
O
OMe
OMe
HO Me
 
125 
N
O
O
OMe
OMe
OH  
126 
                                                                                                                                                                                              
 
N
R5
R4
R1
R3
R2
O
O
O
 
 R1 R2 R3 R4 R5 
127 H H Me H H 
128 Me OMe Me H H 
129 Me OMe EtOH H H 
130 H OMe Me OH H 
131 Me OMe Me H OH 
132 H OMe Me H H 
 
 
NH
O
R1
R2
R4
R3
 
 R1 R2 R3 R4 
133 OMe OMe OMe H 
134 OH OMe H H 
135 OMe OH OMe H 
136 OMe OMe H OH 
 
 
General Chemical Aspects  Chapter 2  
 
38 
 
Chalcones 
OMeR
OH O
R1
 
 R R1 
137 OMe OMe 
138 OH OMe 
139 OH OH 
 
OMeR
OH O
OMe
 
R=OMe 140 
R=OH 141 
 
Dihydrochalcones 
OO
MeOOMe
OH HO
OH
MeO OMe
HO
 
142 
 
Flavonoids 
OR
OMe
OMe
O  
R=OMe 143 
R=OH 144 
OHO
OH
R1
O
OR
OH
OH
 
 R R1 
145 rhamnose OMe 
146 Me OH 
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OR
R1
R3
O
OMe
R2
 
 R R1 R2 R3 
147 OMe OH OMe OMe 
148 OMe OMe OMe OMe 
149 OH OH OH OH 
150 OMe OH OH OH 
151 OMe OH OMe OH 
152 OMe OMe OMe OH 
153 OMe OMe OH OMe 
 
 
 
Terpenes 
OH OH
 
154 
 
Unclassified compounds 
 
O
OH
 
155 HO
H
H H
 
156 
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2.7 Bioactivities 
 The phytochemical studies on Goniothalamus species have resulted in the 
isolation of two very distinct classes of lipophilic secondary metabolites, acetogenins 
and styryl-lactones. Both of them show cytotoxic against a broad array of human tumor 
cell lines including breast, colon, kidney and pancreatic carcinoma cells. They posses 
complex stereochemistry and exist in different stereoisomeric forms. The acetogenins 
and styryl-lactones have different biochemical pathways that take the molecular origin 
approaching or in the mitochondrial membrane and or mitochondrial respiratory 
system.
13
 
A few alkaloids isolated from G. marcanii also exhibited significant cytotoxicity 
against several human tumor cell lines. From the phytochemical reports found so far on 
chemical constituents of Goniothalamus species tested for antitumor activity, G. 
giganteus is the one with most of cytotoxic acetogenins as shown in Table 2.6. 
Table 2.6: Antitumor activity of Goniothalamus species 
Species and Compound Cells IC50 
 
G. borneensis 
41
 
Goniothalamin 1 
 
 
 
P388 
WEHI164 
MOLT-4 
 
 
0.75 g/ml 
1.70 g/ml 
<1 g/ml 
   
G. donnaiensis 53,54 
Donbutocin 24 
Donhexocin 23 
Goniodonin 85 
 
L1210 
HCT-8 
HCT-8
m
 
 
0.81 g/ml 
0.82 g/ml 
<10 g/ml 
   
G. gardneri 59 
Gardnerilin A 116 
 
 
KB 
HCT-8 
Bel 7402 
KB 
 
>10 g/ml 
>10 g/ml 
3.6 g/ml 
5.5 g/ml 
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Species and Compound Cells IC50 
 
Gardnerilin B 117 
 
 
HCT-8 
Bel 7402 
 
4.2 g/ml 
8.5 g/ml 
   
G. giganteus 
27,28,69,70,75,77,78
 
4-Deoxyanomontacin 92 
 
 
 
A-549
a
 
MCF-7
b
 
HT-29
c
 
A-498
d
 
PC-3
e
 
PACA-2
f
 
 
6.45  10
-7
 g/ml 
5.77  10
-7
 g/ml 
1.41  10
-1
 g/ml 
1.50  10
-1
 g/ml 
1.73  10
-1
 g/ml 
1.00  10
-5
 g/ml 
   
(cis and trans)-Annomontacinone 98 
 
HT-29 
PACA-2 
2.55  10
-1
 g/ml 
6.78  10
-1
 g/ml 
cis-Gigantrionenin 102 
 
A-549 
MCF-7 
HT-29 
A-498 
PC-3 
PACA-2 
5.99  10
-2
 g/ml 
2.68  10
-1
 g/ml 
6.94  10
-6
 g/ml 
1.39  10
-2
 g/ml 
1.11  10
-1
 g/ml 
1.15  10
-1
 g/ml 
4-Acetylgigantetrocin A 95 
 
A-549 
MCF-7 
HT-29 
A-498 
PACA-2 
<10
-2
 g/ml 
8.5  10
-1
 g/ml 
< 10
-2
 g/ml 
1.55  10
-1
 g/ml 
< 10
-2
 g/ml 
Annonacin 73 PA1
g
 
SKOV3
h
 
HeLa
i
 
HeLa S3
j
 
MCF-7 
T-24
k
  
BCC-1
l
 
0.452 g/ml 
0.411 g/ml 
0.219 g/ml 
0.426 g/ml 
0.433 g/ml 
0.324 g/ml 
0.427 g/ml 
Gigantransenin A 25 A-549 0.16 g/ml 
   
Gigantransenin B 26 A-549 
MCF-7 
0.21 g/ml 
2.1  10
-1
 g/ml 
   
Gigantransenin C 27 A-549 0.18 g/ml 
   
Goniotetracin 104 A-549 
PC-3 
PACA-2 
3.9  10
-1
 g/ml 
2.1  10
-1
 g/ml 
2.6  10
-2
 g/ml 
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Species and Compound Cells IC50 
(2,4-cis and trans)-Gonioneninone 109 PACA-2 4.5  10
-2
 g/ml 
Goniothalamicin 86 A-549 2.80  10
-1
 g/ml 
Gonionenine 103 PACA-2 4.5  10
-2
 g/ml 
Pyranicin 35 A-549  
MCF-7 
A-498 
PC-3 
PACA-2 
2.8  10
-1
 g/ml 
3.9  10
-1
 g/ml 
1.8  10
-1
 g/ml 
4.1  10
-1
 g/ml 
1.3  10
-3
 g/ml 
Pyragonicin 36 PACA-2 5.8  10
-2
 g/ml 
Goniotrionin 87 
 
A-549 
MCF-7 
HT-29 
A-498 
PC-3 
PACA-2 
7.7  10
-3
 g/ml 
5.3  10
-6
 g/ml 
3.4  10
-1
 g/ml 
2.0  10
-3
 g/ml 
3.6  10
-1
 g/ml 
5.4  10
-3
 g/ml 
   
G. griffithii 
110
 
Goniothalamin 1 
 
HepG2 
HepG2R 
 
8.83 M 
8 M 
   
Altholactone 5 HepG2 
HepG2R 
0.7 M 
6.17 M 
   
Goniodiol 2  HepG2 
HepG2R 
10 M 
8.33 M 
   
G. laoticus 
88
 
3-Acetylaltholactone 64 
 
KB 
BC1 
NCI-H187
 o
 
 
2.9 g/ml 
0.9 g/ml 
1.8 g/ml 
   
Goniotriol 60 BC1 
NCI-H187 
18.8 g/ml 
4.5 g/ml 
   
(+)-Altholactone 5 KB 
BC1 
NCI-H187 
3.5 g/ml 
0.8 g/ml 
0.6 g/ml 
   
(+)-Goniofufurone 11 NCI-H187 
MCF-7 
9.5 g/ml 
18.7 g/ml 
   
9-Deoxygoniopypyrone 15 
 
KB 
NCI-H187 
MCF-7 
22.7 g/ml 
2.6 g/ml 
18.7 g/ml 
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Species and Compound Cells IC50 
   
Howiinin A 52 
 
KB 
BC1 
NCI-H187 
16.6 g/ml 
9.0 g/ml 
1.5 g/ml 
   
(–)-Nordicentrine 123 KB 
NCI-H187 
MCF-7 
0.4 g/ml 
0.4 g/ml 
2.9 g/ml 
   
G. marcanii 
93
 
Marcanine A 127 
 
 
 
 
A-549 
HT-29 
MCF7 
RPMI 
p
 
U251
q
 
 
0.42 M 
0.42 M 
0.42 M 
0.42 M 
0.84 M 
   
Dielsiquinone 132 A-549 
HT-29 
MCF7 
RPMI 
U251 
0.11 M 
1.12 M 
0.11 M 
0.11 M 
0.37 M 
   
Marcanine B 128 A-549 
HT-29 
MCF7 
RPMI 
U251 
0.35 M 
2.12 M 
0.18 M 
0.70 M 
1.40 M 
   
Marcanine C 129  
 
A-549 
HT-29 
MCF7 
RPMI 
1.00 M 
0.33 M 
1.00 M 
0.67 M 
   
Marcanine D 130  
 
A-549 
HT-29 
MCF7 
RPMI 
U251 
0.04 M 
0.35 M 
0.08 M 
0.08 M 
0.28 M 
   
5-hydroxy-3-amino-2-aceto-1,4-
naphthoquinone 124 
A-549 
MCF7 
RPMI 
U251 
2.60 M 
2.60 M 
3.03 M 
3.03 M 
a,o
human lung carcinoma; 
b
human breast carcinoma; 
c
human colon adenocarcinoma; 
d
human kidney carcinoma; 
e
human prostate 
adenocarcinoma; 
f
human pancreatic carcinoma; 
g,h
ovarian cancer cells; 
i,j
cervical cancer; 
k
bladder cancer; 
l
skin cancer; 
m
human 
colon adenocarcinoma; 
n
hepatoma cell-line; 
p
melanoma; 
q
brain carcinoma. 
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3.1 Compounds of Goniothalamus tapisoides 
Eleven compounds have been isolated from the dichloromethane extracts of the 
stem bark of Goniothalamus tapisoides which were listed in Table 3.1. The isolation of 
pure compounds has been done through chromatographic methods (TLC and CC). The 
structures of the isolated compounds were then elucidated by nuclear magnetic 
resonance (NMR), mass spectrometry (MS), infrared spectroscopy (IR) and ultraviolet 
spectroscopy (UV). 
Discussion on the structural elucidation of all the isolated compounds is briefly 
presented in the following section of this chapter. 
 
Table 3.1: Isolated Compounds from Goniothalamus tapisoides 
Compound name Type of compound Yield (mg) 
Goniothalamin 1 Styryl-lactones 1300 
Goniomicin A 157 - 12.3 
Goniomicin B 158 - 7.9 
Goniomicin C 159 Styryl-lactones 14.8 
Goniomicin D 160 Styryl-lactones 18.9 
9-Deoxygoniopypyrone 15 Styryl-lactones 4.4 
Cinnamic acid 155 - 4.0 
Benzamide 161 - 4.8 
Liriodenine 40 Alkaloids 1.2 
Tapisoidin 162 Alkaloids 3.2 
Pterodondiol 164 Terpenes 1100 
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3.1.1 Goniothalamin 1 
O O
1
2
3
4
5
6
7
8
9
13
12
11
10
14
 
1 
 1 was isolated as white crystal needles (mp 80-82°C). 
17
 The mass spectrum 
showed a molecular ion peak at m/z 200, which corresponded to a molecular formula of 
C13H12O2. The UV spectrum revealed maxima at 207, 255 and 284 nm. It showed strong 
bands in IR spectrum 1722, 1249, 752 cm
-1
 corresponding to the resonance of α, β-
unsaturated δ-lactone moiety. 111 
 The 
1H NMR spectrum showed a multiplet δ 7.16-7.26 referring to five aromatic 
protons (H-10 to H-14) of a mono-substituted phenyl ring. The two olefinic proton 
peaks at δ 6.60 (d, J=16.2 Hz) and δ 6.18 (dd, J=16.2 and 6.4 Hz) with a trans 
configuration belonged to H-8 and H-7 respectively. An allylic methylene signal 
observed as a multiplet at δ 2.32-2.37 (m) could be assigned to H-5 and a proton on a 
carbon bearing the oxygen of the lactone group appeared as a multiplet at δ 4.89-4.93 
(m) belonged to H-6. The two proton of the allyl group resonating at δ 5.94 (dd, J=9.9, 
1.4 Hz) and δ 6.75 (ddd, J=9.9, 4.6, 3.2 Hz) belonged to H-3 and H-4 respectively. 
 The 
13
C NMR spectrum showed thirteen carbons; one methylene, ten methine 
and two quaternary carbon. The olefinic carbons C-7 and C-8 resonated at δ 125.9 and δ 
133.0 respectively. A methylene carbon C-5 gave a peak at δ 29.8 meanwhile a methine 
carbon C-6 showed the peak at δ 78.1 due to the deshielding effect by the neighbouring 
oxygen atom. The signals for C-3 and C-4 resonated at δ 121.2 and δ 145.5 respectively. 
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Finally for aromatic carbon peak occured at δ 126.8 which attributed to the two 
aromatic carbons of C-10 and C-14, meanwhile the peak at δ 128.8 corresponding to the 
two aromatic carbons of C-11 and C-13. Another aromatic carbon peak appeared at δ 
128.8 which could be assigned for C-12. The carbonyl carbon of the lactone appeared at 
δ 164.1. 
Comparison of the spectral data with the literature values confirmed that 1 was 
indeed the styryl-lactone, goniothalamin.
17
 
Table 3.2: 
1
H, 
13
C and HMBC Spectral Data of 1 in CDCl3 
 
 
 
 
 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1    
2 164.1   
3 121.2 5.94 (1H, dd) J=9.9, 1.4 2, 5, 12 
4 145.5 6.75 (1H, ddd) J=9.9, 4.6, 3.2 2, 5, 6, 8 
5 29.8 2.32-2.37 (2H, m) 3, 4, 6, 7 
6 78.1 4.89-4.93 (1H, m) 2, 4, 5, 7, 8 
7 125.9 6.18 (1H, dd) J=16.2, 6.4 3, 5, 6, 9 
8 133.0 6.6 (1H, d) J=16.2 6, 9, 10, 14 
9 135.9   
10-14 126.8 7.16-7.26 (5H, m)  
 128.8   
 128.4   
 128.8   
 126.8   
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3.1.2  Goniomicin A 157 
OH
1
2
3
4
5
6
7
9
10
11
13
12
O OH
 
157 
157 was isolated as yellowish amorphous solid. The mass spectrum showed a 
molecular ion peak at m/z 218, corresponding to a molecular formula of C13H14O3. The 
IR spectrum showed strong absorptions bands of O-H stretching at 3344 cm
-1
, C=O 
stretching at 1668 cm
-1
 and C-O stretching at 1329 cm
-1
. 
111
 The UV spectrum revealed 
maximum at 206 and 251 nm. 
The 
1H NMR spectrum showed the aromatic protons at δ 7.19-7.34 referring to 
five aromatic protons (H-9 to H-13) of a mono-substituted phenyl ring. Four olefinic 
protons peaks at δ 6.59, δ 6.20, δ 6.12 and δ 5.96 which belonged to H-7, H-6, H-3 and 
H-2 were observed. H-7 and H-6 were in trans configuration, while H-3 and H-2 were 
in cis configuration. The configurations were determined by a proton signal at δ 4.41 (q, 
J=6.6 Hz) was indicative of oxygen bearing methine proton H-5. Two allylic protons 
resonated at δ 2.76 (m) and δ 2.81 (m) belonged to H-4 and H-4’. 
The 
13
C and DEPT experiment further confirmed the presence of thirteen 
carbons; one methylene, ten methine and two quaternary carbon peaks appeared at δ 
169.6 and δ 136.7 which were most probably belonged to C-1 and C-8 respectively. 
Four olefinic carbons; C-2, C-3, C-6 and C-7, resonated at δ125.6, δ 140.6, δ 131.9 and 
δ 129.9 respectively. C-3 resonated most downfield compared to the other olefinic 
carbons due to the α-β unsaturated resonance effect of carbonyl group at position C-1. 
The methylene carbon C-4 gave a peak at δ 36.61 meanwhile C-5 showed a peak at δ 
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71.5 which were due to the deshielding effect by the neighbouring oxygen atom. Finally 
the five aromatic protons gave signals centred at δ 126.5-128.6 (C-9 to C-13). 
The HMBC correlations of H-2, H-3 to C-1 suggested that the double bond was 
linked to C-1. The correlations of the two olefinic protons H-6, H-7 to C-5 and C-8 
indicated the aromatic ring was connected to C-7. 
157 is a new compound identified as (2Z,6E)-5-hydroxy-7-phenylhepta-2,6-
dienoic acid, named as goniomicin A. 157 upon dehydration and cyclization form the 
styryl-lactone, goniothalamin 1 (compound A) (Scheme 3.1). 
Table 3.3: 
1
H, 
13
C and HMBC Spectral Data of 157 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 169.6   
2 125.3 5.96 (1H, d) J=11.9 1, 3, 4 
3 140.6 6.12 (1H, ddd) J=11.9, 8.5, 3.5 1, 2 
4 36.6 2.76 (1H, m) 
2.81 (1H, m) 
3, 5, 6, 9 
5 71.5 4.41 (1H, q) J=6.6 7 
6 131.9 6.20 (1H, dd) J=16.0, 6.6 4, 5, 8 
7 129.9 6.59 (1H, d) J=16.0 5, 8, 9 
1-OH  6.57 (OH, br s)  
5-OH  6.27 (OH, br s)  
8 136.7   
9-13 126.5 7.19-7.34 (5H, m)  
 128.6   
 127.6   
 128.6   
 126.5   
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Scheme 3.1: Dehydration and cyclization of 157 to form goniothalamin 1 
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3.1.3  Goniomicin B 158 
OH
OMe
O
1
2
3
4
5
6
7
9
10
11
13
12
 
158 
158 was isolated as yellowish amorphous solid. The mass spectrum showed a 
molecular ion peak at m/z 232, corresponding to a molecular formula of C14H16O3. 158 
is similar to 157, except for the methoxyl group at C-1. The IR spectrum showed a 
strong conjugated carbonyl stretch of an ester at 1718 cm
-1
. 
111
 The UV spectrum 
showed absorption bands at 207 and 251 nm suggesting the presence of an aromatic 
ring. 
111
 
The 
1
H NMR spectrum showed a distinct methoxyl group at δ 3.72 (s) which is 
most probably positioned at C-1. H-3 resonated at δ 7.00 (dt, J=15.1, 7.3) was more 
deshielded in 158 compared to 157 due to methoxyl group attachment. Coupling 
constant of H-7, H-6 and H-3, H-2 is 15-16 Hz, this showed that both of it having trans 
configuration. 
 The 
13
C NMR spectrum of this compound is very similar with 157. The 
chemical shift of C-1 (δ 166.8) which is more shielded as compared to C-1 of 157 (δ 
169.6). This is because C-1 is attached to a methoxyl while C-1 of 157 is attached to a 
hydroxyl group. Another difference were the chemical shifts of C-3 and C-4 is more 
deshielded by 5 ppm as (δ 144.7, δ 40.2) respectively compared to those of 157 (δ 140.6, 
δ 36.6). 
The HMBC correlations between methoxyl group and C-1 showed that the 
methoxyl group was linked to C-1. The HMBC cross peaks of 157 and 158 were also 
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similar, thus suggesting that the structure had the same chain but the functional group 
attached to C-1 was different. 
 Therefore, 158 is a new compound identified as (2E, 6E)-methyl 5-hydroxy-7-
phenyl-2, 6-heptadienoate, named as goniomicin B. 
Table 3.4: 
1
H, 
13
C and HMBC Spectral Data of 158 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 166.8   
2 123.9 5.94 (1H, d) J=15.1 1, 4 
3 144.7 7.00 (1H, dt) J=15.1, 7.3 1, 4 
4 40.2 2.54 (2H, dt) J=6.4, 1.4 2, 3, 5, 6 
5 71.6 4.44 (1H, q) J=6.4 3, 7 
6 130.9 6.22(1H, dd) J=16, 6.4 5, 8 
7 131.3 6.61 (1H, d) J=16 5, 9, 11 
8 136.3   
9-13 128.0 7.24-7.38 (5H, m)  
 128.6   
 126.5   
 128.6   
 126.5   
1-OMe 51.6 3.72 (3H, s) 1 
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3.1.4  Goniomicin C 159 
O O
OMe
26
4
5 3
7
8
1 0
11
1 2
14
1 3
H
H
 
159 
159 was isolated as yellowish amorphous solid. The mass spectrum showed a 
molecular ion peak at m/z 232, corresponding to a molecular formula of C14H16O3. In 
the UV region, it absorbed at 206 and 251 nm. Its IR spectrum showed strong 
absorptions bands of C-H stretching at 2925 cm
-1
, C=O stretching at 1731 cm
-1
 and C-O 
stretching at 1241 and 1090 cm
-1
. 
111
 
The 
1
H NMR spectrum showed the aromatic proton signals centred at δ 7.24-
7.37 belonging to five aromatic protons (H-10 to H-14) of a mono-substituted phenyl 
ring. Two olefinic protons peaks at δ 6.68 (d, J=16.0) and δ 6.18 (dd, J=16.0, 6.4) were 
attributable to H-8 and H-7 respectively. A distinct methoxyl group showed signal at δ 
3.36 (s) which was most probably positioned at H-4. H-5 and H-5’ were non-equivalent 
methylene protons resonated at δ 1.87 (dt, J=11.4, 3.2) and δ 2.18 (dt, J=14.6, 3.2). An 
allylic methylene was observed at δ 2.73 (m) could be assigned to the H-3. A proton on 
a carbon bearing oxygen of the lactone group appeared as a multiplet at δ 5.20 (m) 
belonged to the H-6. 
 The 
13
C NMR spectrum showed fourteen carbons; one methyl, two methylene, 
nine methine and two quaternary carbon. Two olefinic carbons; C-7 and C-8 resonated 
at δ 126.6 and δ 132.5 respectively. Meanwhile C-4 and C-6 showed downfield peaks at 
δ 71.4 and δ 76.2 respectively due to the deshielding effect by the neighbouring oxygen 
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atom. Finally four aromatic carbon peaks were observed at δ 126.5-128.6 attributed to 
the five aromatic carbons of C-10 to C-14. 
H-3/H-4, H-4/H-5, H-5/H-6, H-6/H-7 and H-7/H-8 cross peaks were observed in 
COSY spectrum therefore suggesting the sequence of H-3 to H-7. The HMBC 
correlations of the two olefinic protons H-7, H-8 to C-6, C-9 and C-10 indicating that 
the aromatic ring was connected to C-9. 
Therefore, 159 is a new compound identified as the styryl-lactone (E)-4-
methoxy-6-styryltetrahydro-2H-pyran-2-one, named as goniomicin C. 
Table 3.5: 
1
H, 
13
C and HMBC Spectral Data of 159 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1    
2 169.7   
3 35.7 2.73 (2H, dt) J=4.4, 1.4  
4 71.4 3.82 (1H, quin) J=4.4  
5 33.7 1.87 (1H, dt) J=11.4, 3.2 
2.18 (1H, dt) J=14.6, 3.2 
 
6 76.2 5.20 (1H, m)  
7 126.6 6.18 (1H, dd) J=16.0, 6.4 6, 9 
8 132.5 6.68 (1H, d) J=16.0 6, 10, 14 
9 136.0   
10-14 126.7 7.24-7.37 (5H, m)  
 128.8   
 128.3   
 128.8   
 126.7   
4-OMe 56.3 3.36 (3H, s) 4 
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3.1.5 Goniomicin D 160 
O
O
OH
3
4
5
6
17
9
10
12
13
14
15
1 6
H
 
160 
160 was isolated as pale yellow amorphous solid. The mass spectrum showed a 
molecular ion peak at m/z 246, corresponding to a molecular formula of C15H18O3. The 
IR spectrum showed strong absorptions bands of O-H stretching at 3413 cm
-1
, C-H 
stretching at 2917 cm
-1
, C=O stretching at 1662 cm
-1
 and C-O stretching at 1204 cm
-1
. 
111
 The UV spectrum revealed maximum absorption at 206 and 252 nm. 
The 
1H NMR spectrum showed the aromatic protons between δ 7.19-7.34 
referring to five aromatic protons (H-12 to H-16) of a mono-substituted phenyl ring. 
Two olefinic protons peaks at δ 6.63 (d, J=16.0) and δ 6.20 (dd, J=16.0, 6.0), with a 
trans configuration belonging to H-10 and H-9 were observed. Two non-equivalent 
methylene protons of C-1 bearing oxygen of the lactone group appeared at δ 4.13 (d, 
J=9.2) and δ 4.64 (d, J=9.2) belonged to the H-1 and H-1’. The oxygen bearing proton 
H-8 gave a multiplet signal at δ 4.17. 
 The 
13
C NMR spectrum showed 15 peaks confirmed that this compound indeed 
contained fifteen carbons, comprising of four methylene, nine methine and two 
quaternary carbons. Two olefinic carbons peak at δ 128.3 and δ 131.3 belonged to C-9 
and C-10. The carbons C-1 and C-8 resonated at δ 82.9 and δ 77.3 were due to the 
deshielding effect by the neighbouring oxygen atom. 
 The COSY spectrum showed H-6/H-7 and H-7/H-8 cross peaks therefore 
suggesting the sequence of H-6 to H-8. The HMBC correlations of H-9, H-10 to C-8, C-
Results and Discussion  Chapter 3 
 
75 
 
11 confirmed that the aromatic ring was connected to C-9. The correlations of H-1 to C-
5, C-6, C-8 and H-5 to C-3, C-6, as well as of H-4 to C-3, C-6, C-7 supported the 
assignment of a lactone ring. 
Therefore, 160 was identified as (E)-5-(2-hydroxy-4-phenylbut-3-enyl)tetrahy-
dro-2H-pyran-2-one, named as goniomicin D. 
Table 3.6: 
1
H, 
13
C and HMBC Spectral Data of 160 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 82.9 4.13 (1H, d) J=9.2 
4.64 (1H, d) J=9.2 
5, 6, 8 
6, 8 
2    
3 168.9   
4 37.2 2.28 (1H, dd) J=17.6, 7.8 
2.64 (1H, dd) J=17.6, 5.5 
6, 7 
3 
5 58.9 3.82 (1H, d) J=8.7 
4.34 (1H, dd) J=8.7, 2.7 
6 
3, 6 
6 54.1 2.98 (1H, m)  
7 35.6 1.74 (2H, m) 6, 8 
8 77.3 4.17 (1H, m)  
9 128.3 6.20 (1H, dd) J=16.0, 6.0 8, 11 
10 131.3 6.63 (1H, d) J=16.0 8, 12, 16 
8-OH  6.41 (OH, br s)  
11 136.4   
12-16 126.6 7.19-7.34 (5H, m)  
 128.7   
 128.0   
 128.7   
 126.6   
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3.1.6 9-Deoxygoniopypyrone 15 
O
O
O
HO
4
3
1
9
7
5
8
10
1112
13
14 15
H
H
H
 
15 
 15 was isolated as white powder. The mass spectrum showed a molecular ion 
peak at m/z 234, corresponding to a molecular formula of C13H14O4. The IR spectrum 
showed strong absorptions bands of O-H stretching at 3566 cm
-1
 and C=O stretching at 
1720 cm
-1
. 
111
 The UV spectrum with absorptions bands at 206 and 258 nm. 
 The 
1H NMR spectrum showed a multiplet δ 7.28-7.41 referring to five aromatic 
protons (H-11 to H-15) from a mono-substituted phenyl ring. Four deshielded one-
proton signal at δ 4.51 (br s), δ 4.94 (s), δ 4.86 (quin) and δ 3.93 (br s) were indicative 
of oxygen bearing methine protons belonged to H-5, H-7, H-1 and H-8 respectively. 
Two protons at position 9 are non-equivalent methylene protons at δ 1.84 (dd, J=14.2, 
3.6 Hz) and δ 2.58 (dd, J=14.2, 2.1 Hz). 
The 
13
C NMR spectrum showed thirteen carbons; two methylene, nine methine 
and two quaternary carbon. Two quaternary carbon peaks at δ 169.3 and δ 136.8 were 
assigned to C-3 and C-10 respectively. Four carbons, C-1, C-5, C-7 and C-8, resonated 
in between δ 66.2 – δ 74.8 is due to the deshielding effect by the neighbouring oxygen 
atom. Finally the aromatic carbon peaks showed signal at δ 126.2 attributed to the two 
aromatic carbons of C-11 and C-15, meanwhile the peak at δ 129.0 corresponding to the 
two aromatic carbons of C-12 and C-14 and para aromatic carbon peak appeared at δ 
128.4 which was assigned for C-13. The carbonyl carbon of the lactone appeared at δ 
169.3. 
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 Comparison of the obtained spectral data with the literature values confirmed 
that 15 was the styryl-lactone, 9-deoxygoniopypyrone 
103
. 
Table 3.7: 
1
H, 
13
C and HMBC Spectral Data of 15 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 74.8 4.86 (1H, quin) J=2.1  
2    
3 169.3   
4 36.6 2.96 (1H, d) J=20.0 
2.86 (1H, dd) J=20.0, 5.5 
3 
5 66.2 4.51 (1H, br s)  
6    
7 70.6 4.94 (1H, s) 10, 11 
8 68.4 3.93 (1H, br s)  
9 24.1 1.84 (1H, dd) J=14.2, 3.6 
2.58 (1H, dd) J=14.2, 2.1 
 
OH  -  
10 136.8   
11-15 126.2 7.28-7.41 (5H, m)  
 129.0   
 128.4   
 129.0   
 126.2   
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3.1.7 Cinnamic acid 155 
1
9 3
OH
O
2
5
6
7
8
 
155 
155 was isolated as white amorphous solid. The mass spectrum showed 
molecular ion peak at m/z 147, which corresponding to a molecular formula of C9H8O2. 
The UV spectrum revealed maximum wavelength at 216 and 271 nm. 
The IR spectrum showed a band at 3362 cm
-1
 due to the stretching of O–H and a 
band at 1403 cm
-1
 due to C–O stretching. There is also conjugated C=O and C=C 
stretching observed at 1658 and 1601 cm
-1
. 
111
 
The 
1
H NMR spectrum showed the aromatic protons at δ 7.36-7.52 referring to 
five aromatic protons (H-5 to H-9) of a mono-substituted phenyl ring. Meanwhile, two 
olefinic proton peaks were observed at δ 6.45 (d, 1H, J=15.8), δ 7.64 (dd, 1H, J=15.8) 
with a trans configuration, attributable to H-2 and H-3 respectively. 
The 
13C NMR spectrum showed two olefinic carbon peaks at δ 119.6 and δ 
142.9 belonging to C-2 and C-3. Two quaternary carbon peaks at δ 168.0 and δ134.7 
were assigned to C-1 and C-4 respectively. 
Comparison of the spectral data with literature values confirmed that 155 was 
cinnamic acid. 
112
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Table 3.8: 
1
H, 
13
C and HMBC Spectral Data of 155 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 168.0   
2 119.6 6.45 (1H, d) J=15.8 1, 4 
3 142.9 7.64 (1H, d) J=15.8 1, 2, 6, 8 
4 134.7   
5-9 128.2 7.36-7.52 (5H, m)  
 129.1   
 130.3   
 129.1   
 128.2   
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3.1.8 Benzamide 161 
NH2
O
1
3
4
5
6
7
 
161 
161 was isolated as brown amorphous solid. The mass spectrum showed 
molecular ion peak at m/z 121, which corresponding to a molecular formula of C7H7ON. 
The UV spectrum revealed maximum wavelength at 207 and 252 nm. 
The IR spectrum showed two bands at 3384 and 3189 cm
-1
 due to the stretching 
of primary amides (–NH2). The presence of N–H bending at 1617 cm
-1
 and C=O 
stretching at 1647 cm
-1
 were also observed in the spectrum. 
111
 
The 
1
H NMR spectrum showed the aromatic proton signals accumulated 
between δ 7.19-7.34 belonging to five aromatic protons of H-3 to H-7. This pattern was 
typical of mono-substituted phenyl ring. Meanwhile, the 
13
C NMR spectrum showed a 
total of seven peaks, which consists of two quaternary carbon peaks and five aromatic 
carbon peaks centered at δ 169.5, δ 133.4, δ 127.4, δ 128.7 and δ 132.1. 
Therefore, on the basis of the above results and comparison with literature 
values, 161 was confirmed as benzamide. 
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Table 3.9: 
1
H and 
13
C Spectral Data of 161 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) 
1 169.5  
2 133.4  
3-7 127.4 7.42-7.80 (5H, m) 
 128.7  
 132.1  
 128.7  
 127.4  
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3.1.9 Liriodenine 40 
N
O
O
O 1
2
3 4
5
6 a
7
8
11
10
9  
40 
 Liriodenine 40 was isolated as yellow amorphous solid. The mass spectrum 
showed a molecular ion peak at m/z 275, corresponding to a molecular formula of 
C17H9O3N. Other significant fragmentations revealed by the mass spectrum were at m/z 
247, 219, 189, 188 and 162. Fragmentation peaks at m/z 247 [M-CO]
+
 and m/z 219 [M-
CHO]
+
 were due to the cleavage  and the loss of the ketone group. The loss of the 
methylenedioxyl group [M-OCH2O]
+
 give the peak at m/z 189. 
 This alkaloid exhibited a yellow fluorescent in UV light which indicated the 
presence of an oxoaporphine chromophore. 
113
 The IR spectrum exhibited a strong peak 
due to the C=O stretching at 1728 cm
-1
 signified the occurrence of a highly conjugated 
chromophore 
114,115
 with a ketone group enwrapped within the system. 
 The 
1
H NMR spectrum revealed the characteristic AB dd, typical of an 
aporphinic H-4 and H-5 coupling pattern 
113
. H-4 and H-5 resonated at δ 7.79 and δ 8.89 
respectively with a coupling constant of 5.06 Hz each. A singlet was observed at δ 7.21 
attributed to H-3. The methylenedioxyl group attached to the C-1 and C-2 gave a singlet 
of two protons at δ 6.37. 
 Moreover, two sets of doublet at δ 8.67 (J=7.8 Hz) and δ 8.59 (J=7.76 Hz) 
corresponding to two protons at ring D. The former pair was assigned to H-11 and the 
latter was assigned to H-8. H-11 usually resonated more downfield than the other 
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aromatic protons due to deshielding effect of the facing ring A. Two sets of triplet with 
J=7.2 at δ 7.78 and δ 7.58 were observed, which can be attributed to H-10 and H-9. 
 Comparison of the obtained spectral data with the literature values confirmed 
that 40 was the oxoaporphine liriodenine 
114,115
. 
Table 3.10: 
1
H and 
13
C Spectral Data of 40 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) 
1 163.2  
2 165.3  
3 105.6 7.21 (1H, s)  
3a 146.2  
4 129.0 7.79 (1H, d) J=5.06 
5 140.0 8.89 (1H, d) J=5.06 
6a 161.4  
7 179.9  
7a 129.8  
8 131.2 8.59 (1H, d) J=7.8 
9 132.4 7.58 (1H, t) J= 7.2  
10 135.4 7.78 (1H, t) J= 7.2 
11 130.4 8.67 (1H, d) J=7.8 
11a 152.2  
1a 124.5  
1b 139.6  
O-CH2-O 107.6 6.37 (s) 
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3.1.10 Tapisoidin 162 
N
O
OMe
MeO
MeO
1
2
3
4
5
6
7
8
9
10
 
162 
 162 was isolated as brown amorphous solid. The mass spectrum showed a 
molecular ion peak at m/z 311, corresponding to a molecular formula of C18H17O4N. 
The IR spectrum showed strong absorption peaks of C=O group at 1715 cm
-1
. The UV 
spectrum showed absorption bands at 209, 251, 277 and 322 nm, indicating the 
presence of an aristolactam basic structure. 
116
 
The 
1
H NMR spectrum showed three distinct methoxyl singlets at δ 3.96 (s), δ 
4.00 (s) and δ 3.89 (s). Those methoxyls were attached to nitrogen, C-3 and C-4 
respectively. The positioning of the methyl groups were established from the NOESY 
spectrum which showed cross peaks between H-3 and the methoxyl protons attached to 
C-2. In addition, the latter showed correlations with the methoxyl protons of C-1. The 
isolated Pproton, H-3, appeared as a singlet at signal at δ 7.23 (s) belonged to an 
isolated aromatic proton at H-23. All H-5a, H-6a and H-6b resonated as doublet of 
doublets d at δ 4.60, δ 2.73, δ 3.49 indicating that C-5a and C-6 are hydrogenated. To 
the knowledge of the authors, this is the first occurrence of a 5a,6-dihydroaristolactam 
alkaloid.  
Moreover, two sets of doublet of doublets at δ 8.35 (J=8.2, 1.4 Hz) and δ 7.35 
(J=7.9, 1.4 Hz) corresponded to two protons in ring D. The former pair was assigned to 
H-5 and the latter was assigned to H-8. H-5 usually resonated more downfield than the 
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other aromatic protons due to the deshielding effect of the facing ring A. Two sets of 
doublet at δ 7.40 and δ 7.44 were observed, which could be attributed to H-6 and H-7. 
The HMBC spectrum showed proton H-2 correlated to C-1, C-3 and C-10a; H-6 
to C-8; and from H-9 and H-10 to C-5a confirmed the proposed structure of this 
compound.  
In general, aristolactam have no N-oxy functional group and the aromatic 
methoxyl carbon signals are located at δ 55.0-60.0. In the first report of a naturally 
occurring N-oxygenated methoxy aristolactam (Piperlactam S 163), the carbon signal of 
MeO-N is at δ 64.5. 117  
N
O
OMe
HO
MeO
 
163 
  Comparison with the spectral data of Piperlactam S 163 (Table 3.11) with 162 
confirmed that both alkaloids posses the same skeleton; N-oxygenated methoxy 
aristolactam. 
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Table 3.11: 
1
H and 
13
C NMR Spectral Data of 162 and Piperlactam S in CDCl3 
 
N
O
OMe
MeO
MeO
1
2
3
4
5
6
7
8
9
10
 
 
N
O
OMe
HO
MeO
1
2
3
4
5
6
7
8
9
10
11
 
Position 162 Piperlactam S 
48
 
δC δH (ppm), J(Hz) δC δH (ppm), J(Hz) 
1 167.9  162.1  
2 105.9 7.23 (1H, s) 114.1 7.66 (1H, s) 
2a 123.1  118.0  
3 150.5  152.4  
4 155.7  149.4  
4a 123.8  120.3  
5 127.7 8.35 (1H, dd) J=7.9, 1.4 126.9 9.14 (1H, m) 
5a 135.1  126.4  
6 127.9 7.44 (1H, br d) J=7.9 126.0 7.67 (2H, m) 
7 128.7 7.40 (1H, br t) J=7.9 127.6 
8 130.0 7.35 (1H, dd) J=7.9, 1.4 129.3 8.02 (1H, m) 
8a 131.3  131.9  
9 
 
34.8 2.73(1H, t) J=14.0 
3.49 (1H, dd) J=14.0, 6.0 
102.8 7.39 (1H, s) 
10 57.3 4.60 (1H, dd) J=14.0, 6.0 134.1  
10a 134.4  117.1  
N-OCH3 63.7 3.96 (3H, s) 64.5 4.06 (3H, s) 
3-OCH3 59.7 3.89 (3H, s) 3-OH 10.44 (1H, s) 
4-OCH3 56.0 4.00 (3H, s) 59.6 4.03 (3H, s) 
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Therefore, 162 was identified as 1,2,5-trimethoxy-5a,6-dihydrodibenzo[cd,f]in-
dol-4(5H)-one which is a new alkaloid named as tapisoidin. 
Table 3.12: 
1
H, 
13
C and HMBC Spectral Data of 162 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 167.91   
2 105.86 7.23 (1H, s) 1, 3, 4, 10a 
2a 123.09   
3 150.47   
4 155.66   
4a 123.82   
5 127.67 8.35 (1H, dd) J=7.9, 1.4 2a, 7, 10a 
5a 135.07   
6 127.91 7.44 (1H, br d) J=7.9 8 
7 128.65 7.40 (1H, br t) J=7.9 8a 
8 129.99 7.35 (1H, dd) J=7.9, 1.4 5a 
8a 131.27   
9 
 
34.78 2.73(1H, t) J=14.0 
3.49 (1H, dd) J=14.0, 6.0 
5a, 10 
5a, 8a, 10 
10 57.27 4.60 (1H, dd) J=14.0, 6.0 5a 
10a 134.43   
N-OCH3 63.71 3.96 (3H, s)  
3-OCH3 59.68 3.89 (3H, s) 3 
4-OCH3 55.99 4.00 (3H, s) 4 
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3.1.11 Pterodondiol 164 
HO
OHH
9
8
7
6
11
15
1
2
3
4
14 13
12
10
5
 
164 
 Pterodondiol 164 was isolated as colourless needles (mp 110-112°C). The mass 
spectrum showed a fragmentation peak at m/z 222, corresponding to a molecular 
formula of C15H28O2. This fragment arises from the loss of one water molecule from 
pterodondiol. The IR spectrum showed strong absorptions bands of O-H stretching at 
3391 cm
-1
 and alkyl C-H stretching at 2971 cm
-1
 and 2930 cm
-1
. 
111
 
1H NMR spectrum showed three single peaks at δ 1.20, δ 1.11 and δ 0.86 
corresponding to four methyl groups at position 12-15. Methyl group at position 12 and 
13 existed in the same peak at δ 1.20. Twelve protons of 4 methyl groups thus 
suggesting that compound K could be a sesquiterpene.  
The 
13
C NMR spectrum showed fifteen carbons; four methyl, six methylene, two 
methine and three quaternary carbon. Three quaternary carbon peaks at δ 73.1, δ 34.6 
and δ 72.5 could be assigned to C-4, C-10 and C-11 respectively. The carbons for C-4 
and C-11 resonated at around δ 72-73. The signals were deshielded because those 
carbons were attached to the electronegative atom, oxygen. Four methyl carbons C-12, 
C-13, C-14 and C-15 gave a peak at δ 26.2, δ 27.8, δ 22.9 and δ 18.8. Meanwhile six 
secondary carbons which were C-1, C-2, C-3, C-6, C-8 and C-9 resonated at δ 43.2, 
20.2, 41.9, 21.4, 22.6 and 41.1 respectively. Finally signal at δ 54.6 and δ 50.1 were 
attributed to the two tertiary carbons of C-5 and C-7. 
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From the HSQC spectrum, it was shown that C-1 coupled to H-1 and H-1’ at δ 
1.05 and 1.36 respectively, C-3 coupled to H-3 and H-3’ at δ 1.27 and 1.79, C-8 coupled 
to H-8 and H-8’ at δ 1.08 and 1.57 and C-9 coupled to H-9 and H-9’ at δ 1.15 and 1.46 
respectively. 
Comparison of the spectral data with the literature values confirmed that 164 
was the sesquiterpene pterodondiol.
118
 
Table 3.13: 
1
H, 
13
C and HMBC Spectral Data of 164 in CDCl3 
Position δC (ppm) δH (ppm), J(Hz) HMBC (HC) 
1 
1’ 
43.2 1.05 (1H, m) 
1.36 (1H, br d) J=3.5 
5, 12 
2 20.2 1.54 (2H, m)  
3 
3’ 
44.7 1.27 (1H, br d) J=3.5 
1.77 (1H, dt) J=3.5, 1.8 
 
4 73.1   
5 54.6 1.19 (1H, br d) J=2.7  
6 
6’ 
21.4 1.11 (1H, m) 
1.92 (1H, dd) J=2.7, 5.5 
 
 
7 50.1 1.30 (1H, d) J=3.2 12 
8 
8’ 
22.6 1.08 (1H, m) 
1.57 (1H, m) 
 
9 
9’ 
41.1 1.15 (1H, br d) J=3.4 
1.46 (1H, br t) J=3.4 
 
10 34.6   
11 72.5   
12 26.2 1.20 (3H, s) 4, 7, 12 
13 27.8 1.20 (3H, s)  
14 22.9 1.11 (3H, s) 1, 5, 11 
15 18.8 0.86 (3H, s) 3, 5, 9,10 
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3.2 Biosynthetic relationships of the Isolated Compounds 
 Biosynthetic relationships between all the isolated styryl-lactones are proposed 
in Scheme 3.2. This scheme shows that 157 is a precursor of 1 and 158. 1 undergoes 
epoxidation to form 15. It will also undergo hydrogenation and C-methylation to give 
159. 158 will undergoes methylation and cyclisation to form 160. All proposed 
approaches were designed on the basis of references 
119
 and 
120
. 
OH O
OMe
C-Methylation
Dehydration
&
Cyclisation
158157
O O
1
Hydrogenation
&
C-Methylation
Epoxidation
15
159
Methylation
&
Cyclisation
160
OH
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O
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Scheme 3.2: Proposed biosynthetic relationship of 1, 15, 157, 158, 159 and 160 
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4.1 Cytotoxic activity 
 The crude extracts of G. tapisoides were evaluated for cytotoxic activity against 
lung cancer, breast cancer and prostate cancer cell lines. The results showed that hexane 
and dichloromethane extracts inhibited the growth of lung cancer (A549), breast cancer 
(MCF-7) and prostate cancer (DU-145) cell lines. While methanol extract was not 
active for all three cancer cell lines. The results of bioactivity tests on the crude extracts 
are shown in Table 4.1-4.3. 
Table 4.1: Cytotoxic activity of crude extracts from G. tapisoides against lung cancer  
     cell (A549)  
Extracts Abs (490nm) % Viability % Death 
Hexane 0.0480 2.9 97.1 
DCM 0.0470 2.9 97.1 
Methanol 1.4256 87.2 12.8 
Positive control was 5-Fluorouracil (anti-metabolite) EC50=37.2 g/ml 
 
Table 4.2: Cytotoxic activity of crude extracts from G. tapisoides against breast cancer  
     cell (MCF-7)  
Extracts Abs (490nm) % Viability % Death 
Hexane 0.0527 6.2 93.8 
DCM 0.0543 6.4 93.6 
Methanol 0.8030 94.8 5.2 
Positive control was 5-Fluorouracil (anti-metabolite) EC50=59.5 g/ml 
 
Table 4.3: Cytotoxic activity of crude extracts from G. tapisoides against prostate  
     cancer cell (DU-145)  
Extracts Abs (490nm) % Viability % Death 
Hexane 0.0623 9.4 90.6 
DCM 0.0551 8.3 91.7 
Methanol 0.5478 82.3 17.7 
Positive control was 5-Fluorouracil (anti-metabolite) EC50=6.5 g/ml 
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 The isolated compounds were tested on eight cancer cell lines; lung (A549), 
prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), liver (Hep G2), colon (HT-
29), breast (MCF-7) and (MDA-MB-231). Compound A exhibited cytotoxic activity 
against all cancer cell lines except for MDA-MB-231 (Table 4.4), while other 
compounds were inactive against all of the cancer cell lines. 
Table 4.4: Cytotoxic activity of 1 
Cancer cell lines IC50, M 
A549 107.62 ± 4.67 
DU-145 71.79 ± 1.61 
SK-MEL-5 100.14 ± 11.84 
BxPC-3 130.48 ± 7.69 
Hep G2 128.73 ± 1.81 
HT-29 64.17 ± 5.60 
MCF-7 120.37 ± 11.11 
MDA-MB-231 > 150 
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5.1 CONCLUSION 
The chemical study on the dichloromethane extract of the stem bark of 
Goniothalamus tapisoides has led to the isolation of eleven compounds; six styryl-
lactones, a sesquiterpene, two alkaloids, benzylamide and cinnamic acid. Structural 
elucidations were established through spectroscopic methods; NMR (nuclear magnetic 
resonance), MS (mass spectrometry) and IR (infrared spectroscopy). This particular 
Goniothalamus species (Goniothalamus tapisoides) has not been studied chemically and 
biologically before.  
As can be observed from Table 2.2, goniothalamin 1, 9-deoxygoniopypyrone 15, 
cinnamic acid 155 and liriodenine 40 have been previously reported from several 
Goniothalamus sp. However pterodondiol 164 and compounds 157, 158, 159, 160, 161 
and 162 has not been reported so far. In addition, this is the first report of compound B 
as a natural product which is a possible precursor of 1 (Scheme 3.1). While 162 is a new 
aristolactam with N-oxy functional group and this is the first occurrence of such type of 
alkaloid in the Goniothalamus species. 
Cytotoxic activities of the compounds were evaluated against a panel of eight 
cancer cell lines; lung (A549), prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-
3), liver (Hep G2), colon (HT-29), breast (MCF-7) and (MDA-MB-231). Only 
goniothalamin 1 showed potent activity against the cancer cell lines (Table 4.4, page 
114) while the other compounds were inactive. 
This study has shown that Goniothalamus tapisoides is a producer of many 
types of compounds; styryl-lactones, alkaloids, terpenes, acetogenins and it is a good 
source to search for potential bioactive compounds. Studies such as hemisynthesis or 
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microbial transformation, drug design and QSAR based on goniothalamin can be the 
subject of further investigations. 
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Figure 5.1: Structures of compounds isolated from Goniothalamus tapisoides 
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6.1 GENERAL METHODS 
The Shimadzu 1650 PC ultraviolet-visible spectrometer were used to obtain the 
ultraviolet spectra, samples were dissolved in MeOH. 
The infrared were taken on a Perkin Elmer Spectrum 400 FT-IR/FT-FIR 
Spectrometer. 
NMR spectra were taken in deuterated chloroform on the JEOL JNM-LA 400 
FT-NMR system. Mostly of Mostly of 13C, DEPT, HSQC and HMBC spectra were 
obtained from JEOL ECA 400. Chemical shifts are given in ppm on δ scale. 
The mass spectra were obtained on Shimadzu GCMS-QP2010 Plus, sample 
were dissolved in MeOH. 
Silica gel 60 (0.063-0.200 mm) and silica gel 60 (0.040-0.063 mm) were used 
for the column chromatography. Aluminium supported silica gel 60 F254 plates was used 
for TLC. The spots on the TLC were visualized under ultra-violet (UV) light (254 nm 
and 365 nm) followed with spraying by vanillin reagent.  
Dragendorff’s reagent 
Solution A : Bismuth (III) nitrate (0.85 g) in a mixture of 10 mL glacial acid and 40 
mL distilled water. 
Solution B : Potassium iodide (8.0 g) in 20 mL distilled water. 
Stock solution : A mixture of equal volume of solution A and solution B. 
Spray reagent : The stock solution (20 mL) was diluted in a mixture of 20 mL glacial  
  acetic acid and 60 mL distilled water. 
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Dragendorff’s test: A positive result is indicated by the formation of orange precipitates  
       or spots. 
Vanillin reagent 
Spray reagent : Diluting 10 ml of sulphuric acid with 90 mL of water in 100 mL 
ethanol  
  and followed by adding 10 mg vanillin powder. 
Treatment : Heat at 100°C until coloration appears. 
Vanillin test : A positive result is indicated by the formation of blue or red color spots. 
6.2 PLANT MATERIALS 
The stem bark of Goniothalamus tapisoides was collected from Sarawak. 
Voucher specimen (HUMS 000108) is deposited in the Herbarium of Universiti 
Malaysia Sarawak, Kota Samarahan, Sarawak. 
6.3 EXTRACTION 
The dried and milled stem bark of G. tapisoides was first defatted with hexane 
for 3 days and filtered. The filtrate was concentrated under reduced pressure to yield a 
hexane extract. The plant material was then air dried and moistened with 25% ammonia 
solution and left to soak overnight. The alkaline medium ensures that any alkaloids 
presence in the bark will be in the free base or unionized state.  
The plant material was then extracted with dichloromethane (CH2Cl2) by 
soaking them in large beakers for about three days. The dichloromethane extracted will 
be concentrated by using rotary evaporator. The extraction method depicted above was 
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continued with methanol. The yield of extracts for hexane (25 g), dichloromethane (43 g) 
and methanol (24 g) were obtained. The methanol crude extract was kept for future use. 
6.4  ISOLATION AND PURIFICATION 
20 g of dichloromethane crude was subjected to column chromatography (CC) 
over silica gel. The amount of silica gel used was based on the ratio of 1 g of crude 
extract to 30 g of silica gel. The isolation step was based on gradient elution method. 
The solvent systems used were hexane, hexane-dichloromethane, dichloromethane, 
dichloromethane-methanol and methanol to furnish 11 fractions as stated in Table 6.1. 
Table 6.1: Solvents used for column chromatography of crude DCM extract 
Ratio Solvents Fractions 
         100 : 0 Hexane 1 
 80 : 20 Hex : DCM 2 
 50 : 50 Hex : DCM 3 
 20 : 80 Hex : DCM 4 
         100 : 0 DCM 5 
98 : 2 DCM : MeOH 6 
95 : 5 DCM : MeOH 7 
 90 : 10 DCM : MeOH 8 
 80 : 20 DCM : MeOH 9 
 50 : 50 DCM : MeOH 10 
         100 : 0 MeOH 11 
 
Each fraction was tested on thin layer chromatography (TLC) for purity. 
Fractions which have spots with similar Rf values and stains on the TLCs were 
combined and treated as a group. The combined fractions were then subjected to 
repeated CC or preparative TLC until a single spot on the TLC was obtained. 
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Table 6.2: Chromatographic Solvent Systems and Yield of Compounds from 
Goniothalamus tapisoides (stem bark) 
Solvent system Compound Yield (mg) 
   50 : 50 
Hexane : DCM 
Goniothalamin 1300 
98 : 2 
    DCM : MeOH 
Liriodenine 
9-deoxygoniopypyrone 
Tapisoidin 
 
Benzamide 
Cinnamic acid 
1.2 
4.4 
3.2 
 
4.8 
4.0 
95 : 5 
    DCM : MeOH 
Pterodondiol 1100 
90 : 10 
  DCM : MeOH 
Goniomicin A 12.3 
80 : 20 
  DCM : MeOH 
Goniomicin B 7.9 
50 : 50 
  DCM : MeOH 
Goniomicin C 
  
Goniomicin D 
14.8 
 
18.9 
 
6.5 CYTOTOXIC ASSAY 
Cytotoxicity of the compounds were evaluated against a panel of 8 cancer cell 
lines; lung (A549), prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), liver 
(Hep G2), colon (HT-29), breast (MCF-7) and (MDA-MB-231). These cancer cell lines 
were chosen from the National Cancer Institute (NCI) list of 60 cancer cell lines for 
drug screening and drug treatment conditions were done according to the NCI 
recommendations (Boyd, 1995). 
Cell lines were cultured in DMEM media supplemented with 2 mM L-glutamine, 
10% foetal bovine serum, 50 µg/ml gentamycin and 2.5 µg/ml amphotericin B, 
maintained in a 37ºC humid atmosphere of 5% CO2 cell incubator. Samples and drug 
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standards (cisplatin and vinblastine sulphate) were dissolved in DMSO and immediately 
diluted with DMEM media to yield a final DMSO concentration of less than 0.5% v/v.  
Cells were plated into 96-well microplates at 5,000–10,000 cells per well and 
maintained in the cell incubator for 24 hour. Then, 100 µL of samples were introduced 
in triplicates to a final concentration of 15–200 µM, with the exception of sample 5 that 
was further diluted down to 4 µM in BxPC-3 and HT-29 cell lines. Drug standards were 
also introduced to a final concentration of 0.03 - 2000 µM (cisplatin) and 0.002 - 100 
µM (vinblastine sulphate). Cells were further incubated for 48 hours and then, cell 
viability was determined according to the manufacturer protocol of a commercial MTS 
assay kit (CellTiter 96 AQueous® One Solution, Promega). Culture media were carefully 
refreshed with 100 µL of DMEM media, followed by 20 µL per well of MTS reagent. 
Microplates were returned to the incubator for 1  2 hours and absorbance of the 
formazan product was read on a microplate reader at 490nm with 690nm as the 
background wavelength (Infinite 200, Tecan, Männedorf, Swizerland). IC50 of samples 
and drug standards were determined using dose-response curves in Prism 5.02 software 
(GraphPad Software Inc., La Jolla, CA, USA). 
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6.6 General Spectral Data of Isolated Compounds 
Goniothalamin   
O O
 
State    : White crystals 
Molecular formula  : C13H12O2 
UV λmax nm   : 207, 255, 284 
IR υmax    : 1722, 1249, 752 
Mass Spectrum m/z  : 200 
1
H-NMR   : Refer Table 3.2 (pg 46) 
13
C-NMR   : Refer Table 3.2 (pg 46) 
 
Goniomicin A  
OH
O OH
 
State    : Yellowish amorphous solid 
Molecular formula  : C13H14O3 
UV λmax nm   : 206, 251 
IR υmax    : 3344, 1668, 1634, 1329 
Mass Spectrum m/z  : 218 
1
H-NMR   : Refer Table 3.3 (pg 50) 
13
C-NMR   : Refer Table 3.3 (pg 50) 
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Goniomicin B 
OH
OMe
O  
State    : Yellowish amorphous solid 
Molecular formula  : C14H16O3 
UV λmax nm   : 207, 251 
IR υmax    : 3436, 2926, 1718, 1659, 1209, 1168 
Mass Spectrum m/z  : 232 
1
H-NMR   : Refer Table 3.4 (pg 59) 
13
C-NMR   : Refer Table 3.4 (pg 59) 
 
Goniomicin C 
O O
OMe
H
H
 
State    : Yellowish amorphous solid 
Molecular formula  : C14H16O3 
UV λmax nm   : 206, 251 
IR υmax    : 1731, 1241, 1090 
Mass Spectrum m/z  : 232 
1
H-NMR   : Refer Table 3.5 (pg 67) 
13
C-NMR   : Refer Table 3.5 (pg 67) 
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Goniomicin D 
O
O
OH
 
State    : Pale yellow amorphous solid 
Molecular formula  : C15H18O3 
UV λmax nm   : 206, 252 
IR υmax    : 3413, 2917, 1662, 1204 
Mass Spectrum m/z  : 246 
1
H-NMR   : Refer Table 3.6 (pg 75) 
13
C-NMR   : Refer Table 3.6 (pg 75) 
 
9-deoxygoniopypyrone  
O
O
O
HO
H
H
H
 
State    : White powder 
Molecular formula  : C13H14O4 
UV λmax nm   : 206, 258 
IR υmax    : 2932, 1720 
Mass Spectrum m/z  : 234 
1
H-NMR   : Refer Table 3.7 (pg 83) 
13
C-NMR   : Refer Table 3.7 (pg 83) 
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Cinnamic acid 
OH
O
 
State    : White amorphous solid 
Molecular formula  : C9H8O2 
UV λmax nm   : 216, 271 
IR υmax    : 3362, 1658, 1601 
Mass Spectrum m/z  : 147 
1
H-NMR   : Refer Table 3.10 (pg 87) 
13
C-NMR   : Refer Table 3.10 (pg 87) 
 
Benzylamide  
NH2
O
 
State    : Brown amorphous solid 
Molecular formula  : C7H7ON 
UV λmax nm   : 207, 252 
IR υmax    : 3384, 3189, 1647, 1617 
Mass Spectrum m/z  : 121 
1
H-NMR   : Refer Table 3.9 (pg 91) 
13
C-NMR   : Refer Table 3.9 (pg 91) 
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Liriodenine    
N
O
O
O
 
State    : Yellow amorphous solid 
Molecular formula  : C17H9O3N 
UV λmax nm   : 209, 306 
IR υmax    : 1728, 965, 865 
Mass Spectrum m/z  : 275 
1
H-NMR   : Refer Table 3.10 (pg 95) 
13
C-NMR   : Refer Table 3.10 (pg 95) 
 
Tapisoidin 
N
O
OMe
MeO
MeO
 
State    : Brown amorphous solid 
Molecular formula  : C18H17O4N 
UV λmax nm   : 209, 251, 277, 322 
IR υmax    : 2938, 1715 
Mass Spectrum m/z  : 311 
1
H-NMR   : Refer Table 3.12 (pg 100) 
13
C-NMR   : Refer Table 3.12 (pg 100) 
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Pterodondiol    
OH OH
 
State    : Colorless needles 
Molecular formula  : C15H28O2 
UV λmax nm   : 205 
IR υmax    : 3391, 2971, 2930 
Mass Spectrum m/z  : 222 
1
H-NMR   : Refer Table 3.13 (pg 108) 
13
C-NMR   : Refer Table 3.13 (pg 108) 
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